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Type 2 diabetes mellitus (T2DM) has reached epidemic proportions worldwide. The burden of 
T2DM in both developed and developing countries has warranted much attention and strong 
actions to mitigate this disease. In the past few decades, the global prevalence of T2DM has 
dramatically increased. According to the World Health Organisation (WHO), about 346 million 
people in the world have diabetes, in which T2DM accounts for 90%. It is projected that deaths 
from T2DM will double from 2005 to 2030, and 80% of the mortality will occur in low and 
middle-income countries.  
 
While T2DM is the fastest growing chronic disease, Asia has the largest number of cases, and 
the prevalence of T2DM in Vietnam has increased twofold from 2.7% in 2002 to 5.4% in 2012. 
Therefore, it is important to investigate whether physical activity and certain components of 
the traditional Vietnamese diet can offer some protection against this disease. Epidemiologic 
research on protective factors, together with understanding the disease mechanism, will provide 
an opportunity for early detection, management, control and treatment by implementing 
effective interventions based on the identified factors in a timely manner. However, little 
information is currently available on the protective and modifiable lifestyle factors in Vietnam. 
A case-control study was conducted to investigate the risk factors of T2DM; especially, the 
relationship between physical activity, tea and coffee consumption, and the risk of T2DM for 
the Vietnamese population. These three protective factors are modifiable and can be promoted 
to the population for better T2DM prevention and control. The present study represents the first 
analytical assessment of these three factors with regard to T2DM in Vietnam. The findings 
provide epidemiological evidence for better understanding, control and prevention of T2DM 





Recruitment of participants took place at one hospital in Hanoi located in northern Vietnam. A 
total of 600 incident T2DM patients and 600 hospital-based controls were recruited during 18 
months of data collection at the tertiary hospital. Frequency matching on age and gender 
between case and control groups was applied during subject recruitment, upon satisfying the 
prescribed selection criteria. The WHO diagnostic criteria of 2006 for T2DM were used to 
confirm the disease status. Face-to-face interviews were conducted using a validated and 
standardised questionnaire, specifically a food frequency questionnaire (FFQ) developed for 
the Vietnamese population. Detailed information was sought on demographic characteristics, 
dietary habits and lifestyle including alcohol drinking, tobacco smoking and habitual physical 
activity. The reference period of the FFQ was set before the first diagnoses of T2DM for cases 
and excluding subjects who had changed dietary habits. Descriptive statistics, logistic 
regression analyses were conducted to assess the associations between exposure variables of 
interest, namely, tea and coffee consumption, physical activity, and the T2DM risk. Plausible 
confounding factors including age (years), sex (female, male), education level (≤secondary 
school, >secondary school), occupation (physically heavy job, physically light job), family 
history of diabetes in first-degree relatives (yes, no), alcohol consumption (yes, no), smoking 
status (never, former, current), body mass index (BMI) (kg/m2), waist-hip ratio (high WHR: 
males≥ 0.9, females≥0.85, low WHR: males<0.9, females<0.85) hypertension (yes, no), total 
cholesterol (mmol/l), and total energy intake (kcal). Both crude and adjusted odds ratios (ORs), 
together with their 95% confidence intervals (CI) and corresponding test of linear trend, were 





A total of 1198 eligible participants (599 cases and 599 controls) were available for analysis. 
The average age of participants was 58.4 years (SD 6.6) and 46% were men. The mean age 
was 58.1 (SD 6.6) for men and 58.7 (SD 6.5) for women.  
Tea consumption: In univariate analysis, tea consumers had a significantly lower risk of 
T2DM than non-consumers (OR 0.76, 95%CI 0.60 to 0.96). Adjustment for potential 
confounders including demographics, clinical variables, biomarkers, and anthropometrics did 
not alter the result much (OR 0.75, 95%CI 0.57 to 0.99). Similarly, compared to non-
consumers, individuals consuming >4 cups of tea per day was associated with T2DM (OR 0.67, 
95%CI 0.48 to 0.93). The inverse association remained significant after accounting for 
plausible confounding variables (OR 0.59, 95%CI 0.40 to 0.87). Participants with cumulative 
exposure >40 cup-years or >10 years of tea consumption had significantly lower risks of T2DM 
when compared to their counterparts at the same consumption level, the respective OR (95% 
CI) being 0.65 (0.47 to 0.91, P for trend 0.013) and 0.66 (0.47 to 0.92, P for trend = 0.015). 
These results indicated that regular green tea consumption was associated with a decreased risk 
of T2DM. 
 
Coffee consumption: Overall, participants who consumed 1-3 cups of coffee per day were 
associated with a lower risk of T2DM than non-consumers (OR 0.55, 95%CI 0.34 to 0.88, P 
for trend <0.05) after adjusting for confounders. Women consuming 1-3 cups of any type of 
coffee daily were associated with a reduced odds (OR 0.25, 95%CI 0.11 to 0.55, P for trend 
<0.001) relative to non-consumers. A similar relationship was also observed for men, albeit 





Physical activity: The control subjects reported significantly longer duration of moderate 
activity and physically more active in daily life than their diabetic counterparts. Increased 
engagements in such leisure time activities were associated with reduced T2DM risk after 
adjustment for confounding factors. A significant inverse dose–response relationship was also 
evident for total physical activity exposure, with adjusted OR 0.66 (95%CI 0.48 to 0.91) for 
engaging in 26 or more metabolic equivalent tasks (MET)-hours per week, relative to those 
with less than 13 MET-hours per week.  
 
Conclusions 
The findings of this case-control study suggested inverse associations between regular and 
long-term tea and coffee consumption and the risk of T2DM among Vietnamese adults. The 
study also provided epidemiological evidence that habitual physical activity could reduce the 
risk of T2DM, which is important for the promotion and encouragement of leisure time exercise 
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CHAPTER 1: INTRODUCTION 
 
 
This chapter provides an overview of the epidemiology of type 2 diabetes mellitus (T2DM) 
and systematically reviews the associated factors ofT2DM in Vietnam. Particularly, a case-
control study design including location, objectives, and its significance will be presented. The 
chapter will also briefly describe the scope and contents of next chapters. 
 
1.1 Background 
T2DM has reached epidemic proportion as a non-communicable disease (Zimmet, Alberti, and 
Shaw 2001). The burden of T2DM in both developed and developing countries has warranted 
attention and urgent actions to mitigate the effect of this disease. Its high prevalence has raised 
a concern on the global burden of T2DM (Hu 2011). According to the WHO (2011), about 346 
million people in the world have diabetes, in which T2DM accounts for 90%. It is projected 
that deaths from diabetes will double from 2005 to 2030. In 2004, it was estimated that about 
3.4 million people worldwide died from consequences of high blood sugar, and 80% of deaths 
occurred in low and middle-income countries (WHO 2011).  
 
Vietnam is a developing country facing the emerging burden of T2DM because the nutritional 
transition and lifestyle have been changing fast for the last two decades (Bassett 2005, Khan 
and Khoi 2008) from the traditional Vietnamese diet to Westernised diet and become more 
sedentary. Epidemiology and risk factors of T2DM in Vietnam is little known, despite several 
cross-sectional studies have been conducted in the past decades. Therefore, the epidemiology 
of T2DM including its prevalence and associated risk factors are systematically reviewed to 




According to the 2012 national diabetes report (National Hospital of Endocrinology 2012), the 
occurrence of T2DM was estimated to be 5.4% overall in Vietnam but varied between rural 
(5.2%) and urban (6.7%) areas (Pham and Eggleston 2016). It was anticipated that the 
prevalence of T2DM would continue to rise due to changes in the dietary pattern of healthy 
foods and lifestyle and no effective action being taken (National Hospital of Endocrinology 
2012). It is important to investigate whether physical activity and certain components of the 
traditional Vietnamese diet can offer protection against this chronic disease. Among protective 
factors for T2DM, physical activity is one of modifiable factors for an effective intervention to 
reduce the incidence of T2DM. For example, in the general population, walking 2.5 hours a 
week is associated with a 63% reduction in developing T2DM compared to walking less than 
one hour a week (Jeon et al. 2007). Recently, the beneficial roles of tea and coffee consumption 
in regard to reduced risk of T2DM have been suggested in several populations, but inconsistent 
findings remained. Vietnam is one of the Asian countries that have the traditional culture of 
daily green tea consumption. Coffee is widely produced in Vietnam. Although it is perceived 
that a low proportion of coffee drinkers, the increasing trend of consumption has been shown 
recently. Therefore, tea, coffee consumption and physical activity are given a priority to 
investigation related to T2DM risk. This type of research may offer opportunities to develop 
population-based strategies for T2DM prevention. In view of the rising prevalence of T2DM, 
a hospital-based case-control study was conducted to investigate the association between 
modifiable risk factors namely; tea and coffee consumption, physical activity and T2DM risk 
among Vietnamese adults. The hospital setting was chosen to recruit newly diagnosed cases of 





1.2 Study location 
Hanoi city is the capital of Vietnam located in the North region with approximately 3.4 
thousand km2 (Figure 1). According to the 2009 Vietnam Population and Housing Census, the 
population of Hanoi was 6.5 million in which about 1.6 million aged 40-65 years. Residents 
lived in urban area accounting for 40%.  
 
1.3 Study design 
A case-control study was conducted to determine the risk factors of T2DM. Recruitment of 
participants took place at one hospital located in Hanoi, Vietnam. A total of about 600 newly 
diagnosed T2DM cases and 600 hospital-based controls (free of T2DM) were recruited during 
the period of data collection, 2013-2015. Frequency matching on age and gender between case 
and control groups was implemented, during the recruitment of participants. The WHO 
diagnostic criteria of 2006 for T2DM were used to confirm the disease. Face-to-face interviews 
were conducted by using a questionnaire, which has been validated and standardised for the 
Vietnamese population. The survey included demographic, lifestyle and food frequency 
questionnaire. Adjusted odds ratios were calculated to assess the associations between 
exposure variables of interest, namely tea and coffee consumption, and physical activity, and 
T2DM risk. 
 
1.4 Objectives of the study 
The primary aim was to ascertain the protective factors of T2DM in Vietnam. Specifically, the 
roles of tea and coffee consumption and physical activity on the T2DM prevalence were 
investigated. The particular objectives of the study were as follows: 
1. To systematically review the prevalence of, and risk factors for, T2DM in Vietnam; 




3. To assess the association between coffee consumption and the risk of T2DM; 
4. To examine the relationship between habitual physical activity and the risk of T2DM.  
 
 
Figure 1: Study location (Hanoi city) and data collection procedure 
 
1.5 Significance of the Study 
The proposed study presents the first attempt to investigate the role of tea and coffee beverages 
and physical activity on the T2DM prevalence in Vietnam. Although little is known about 
T2DM in Vietnam, an upward trend in prevalence has been evident in recent years; probably 
due to rapid economic development, dietary changes and sedentary behaviours influenced by 
the transition to modern lifestyle during the past decade. Therefore, it is important to conduct 
an epidemiological study to provide information on associated factors with T2DM pertinent 




between tea and coffee consumption and the risk of T2DM. Furthermore, we also assess the 
relationship between physical activity and the risk of T2DM among Vietnamese adults. While 
existing evidence for their effect appears to be inconsistent across different populations, the 
present case-control study will address the gap in the literature, especially since tea and coffee 
are the daily consumed beverages in Vietnam. From the perspective of public health, findings 
of the present study have important implications for primary prevention of this emerging 
chronic disease through modifying behaviour and lifestyle.  
 
1.6 Scope of the study 
A hospital-based case-control study was implemented at Thanh Nhan Hospital, which is 
located in the catchment covering both rural areas and urban areas of Hanoi. The hospital is a 
general hospital of Hanoi consisting of 600 beds, 39 departments and 853 staff. According to 
an annual report, there were more than 300,000 patients, of whom half were inpatients, treated 
in this hospital in 2009. About 5,000 diabetic patients were treated, monitored, and managed 
by the hospital in 2012. It was estimated that on average 30-40 cases of T2DM patients are 
newly diagnosed per month, which met the sample size requirement of this study design within 
the data collection time frame. 
 
1.7 Outline of the thesis 
This thesis consists of six chapters. Chapter one provides a brief introduction of T2DM and 
an overview of the study location. The first chapter also includes the study design, objectives, 
significance and scope of the study. 
 
Chapter two reviews the pertinent literature on the topic of the study. It provides a review of 




factors related to T2DM will also be elaborated and briefly discussed in various sections of 
the second chapter.  
 
Chapter three presents the methodology used in the study, which includes the issues on study 
instruments, ethical considerations, sample size calculation, the procedures of data collection 
and management, data cleaning, and statistical analysis. 
 
Chapter four provides the detailed results of the study. It also encompasses some comparisons 
and sensitivity analyses of subgroups of interest. 
 
Chapter five gives discussions of the results, particularly on the findings from the study in 
relation to the literature and previous studies. The chapter also summarises the limitation of 
the study.  
 
Chapter six provides the conclusion and makes recommendations for future research and 
T2DM prevention programmes.  
 
Ethics approval letters, information sheet, consent form, questionnaires, publications and 
other relevant documents are enclosed in the Appendices.  
 
To summarise, along with rapid economic growth and urbanisation, Vietnam is one of the 
Asian developing countries that has experienced lifestyle and dietary changes towards 
unhealthy foods, including increasing fat andmeat consumption (Khan and Khoi 2008). There 
are also concerns about increasing physical inactivity (Ta 2008, Ta et al. 2010, Le et al. 2004), 




adults. Increased life expectancy (Hoi et al. 2009) has resulted in a rapid growth in the number 
of older persons, partly contributing to a high prevalenceof T2DM. However, no analytical 
studies have been conducted to provide evidence of the role of regular tea and coffee 
consumption and habitual physical activity on T2DM in Vietnam. Therefore, this case-control 
study serves as the first analytical epidemiologic study to investigate the associations between 
these factors and T2DM risk among Vietnamese adults. Its findings may contribute to the 






CHAPTER 2: LITERATURE REVIEW 
 
 
This chapter describes the general epidemiology of T2DM and examines the associations 
between tea and coffee consumption, and physical activity and the risk of T2DM. Some 
materials presented in this chapter have been published in the journal article (Nguyen et al. 
2015). 
 
2.1Global trend and burden 
The prevalence of T2DM is increasing dramatically in the world, especially in low and middle-
income countries. According to the recent review conducted by Brono and Landi (2011), it is 
predicted that China and India will have the greatest numbers of people affected by this disease. 
In developed countries, the upward trend of T2DM is more noticeable than that of developing 
countries. However, the trend may be mainly explained by the prolonged survival of patients 
and the increase in life expectancy of the population. In other words, T2DM is more likely to 
occur amongst elderly people in Western developed countries.  
 
Studies have indicated that onset at the younger age is becoming a tendency (Alberti et al. 
2004). Therefore, T2DM will impose its burden not only on individuals but also on the health 
care systems in many societies (Bruno and Landi 2011). Unlike developed countries, T2DM 
has become a new epidemic and a major public health problem in low and middle-income 
countries. The prevalence of T2DM is increasing in both urban and rural areas but tends to be 
higher in urban areas. This tendency may reflect a difference in the pace of urbanisation and 





Furthermore, differences in lifestyle and dietary patterns may also explain the lower number of 
patients in rural areas compared to that of urban areas (Pham and Eggleston 2016). For instance, 
in a systematic literature review of South Asian countries, Gupta and Kumar (2008) showed 
that current prevalence rates were 5-16% in urban areas and 2-8% in rural areas. A population-
based survey with 4,757 participants aged over 20 years in Bangladesh in 2006 showed that 
prevalence of T2DM in rural areas was 6.8% compared to 2.3% in an earlier survey (P< 0.05) 
(Rahim et al. 2007).  
 
Regardless of the increasing number of new cases of T2DM, those who suffered from the 
disease faced its complications, reduced quality of life, increased health care–related costs, and 
risk of other chronic diseases (Tan 2004, Benhalima et al. 2011). Unlike infectious diseases 
which usually have specific biological agents such as viruses, microbacteria, fungi, and 
protozoa, T2DM is a non-communicable disease with its onset depending much on genetic, 
anthropometric, and environmental factors. For public health practice, modifiable factors such 
as dietary factors and lifestyle can be changed to prevent, manage, and control T2DM.  
 
Furthermore, recent studies showed that the epidemiological features of T2DM can vary 
amongst countries significantly, especially in low and middle-income countries. This 
characteristic may offer many opportunities for investigating T2DMworldwide. For example, 
the most commonly used predictor for the development of T2DM is overweight and obesity. 
However, the use of BMI cut-points for Caucasians to classify overweight and obesity may not 
be appropriate to Asians (WHO 2000). Therefore, the WHO has advised using BMI more 





Although there are reliable estimates of the global or national prevalence of T2DM, these 
estimates are local and incomparable across the world. Many factors affecting the estimation 
of prevalence have been noted, such as place of residence, country of residence, ethnicity, 
lifestyle, obesity, socio-economic status, race, gender, age and so on (Jain and Saraf 2010). 
None of the studies so far have all such information to estimate the T2DM prevalence. 
However, the upward trend of T2DM in almost all countries has been identified and warranted 
further public health actions to prevent and control this epidemic effectively. Besides, many 
studies revealed that rural areas are less affected by T2DM when compared with urban areas. 
However, high undiagnosed T2DM in rural areas were problematic in many developing 
countries, which may underestimate its T2DM prevalence compared to its urban counterpart 
(Dong et al. 2005). 
 
Premature morbidity and mortality are often used as indicators to assess the burden of a disease. 
Annually, there are about 4 million deaths worldwide due to T2DM, which is almost the same 
as the number of deaths attributed to smoking (The Lancet Editorial 2009). Patients with T2DM 
tend to have co-morbidity such as cardiovascular diseases (CVD) (Huxley et al. 2015). This 
co-morbidity not only affects diabetic patients but also has a large impact on the health care 
system. For example, Mody and colleagues (2006) assessed the effects of cardiovascular co-
morbidity on total and diabetes-related healthcare costs in the year 2002 in the United States. 
The result indicated that T2DM patients with cardiovascular co-morbidity had significantly 
higher total healthcare cost compared to those who had no co-morbidity.  
 
Increasing mortality in T2DM is associated with multiple risk factors. A systematic review and 
meta-analysis showed that approximately a two-fold increase in the mortality risks in T2DM 




2013). A ten-year cohort study conducted in New Zealand indicated that glycaemic parameters 
were more strongly associated with the mortality rate for ten years of follow-up than six months 
of follow-up (Florkowski et al. 2001). An intervention study aimed to avert complications 
related to glycaemic control, involving management of hypertension and dyslipidaemia, in 
order to reduce the mortality of T2DM in Denmark. After six years of follow-up, the 
intervention altered the risk of T2DM related complications but could not reduce the mortality 
rate (Gagliardino 2002).  
 
In contrast, a study of Japanese–American men and women found that T2DM was a strong 
independent risk factor for cardiovascular mortality (Imazu et al. 2002). The major causes of 
increased mortality amongst T2DM patients include cardiovascular diseases and infection-
related complications. Cardoso and Salles (2007) concluded that there was a six-fold excess 
infection-related mortality amongst T2DM patients when compared to the general Brazilian 
population. Micro-and macro-vascular complications such as diabetic retinopathy and 
blindness were identified as the main risk factors for the increased mortality in T2DM patients 
(Adler et al. 2000, Holman et al. 2008).  
 
Costs of diagnoses, treatment, and care for T2DM have large economic impacts on patients, 
families, and health care systems in many countries. The WHO (2005) estimated that China 
would spend about $558 billion in fixed national income for heart diseases, stroke, and diabetes 
alone in the period 2006-2015. Rodbard and co-workers (2010) conducted a study of 3,551 
participants in the United States and concluded that out-of-pocket expenses for both annual 
medical cost ($1,158) and monthly prescription cost ($144) of T2DM patients were 
significantly higher than those of the non-diabetic group. A large survey in China in which 




high economic burden placed a challenge to the health care system. Furthermore, that study 
also reported that the annual direct medical expense of T2DM patients with complications 
($1,080) including micro-and macro-vascular diseases was significantly higher than that of 
patients without complications ($514) (Wang et al. 2009). The United Nations and the WHO 
predicted that in 2030, about $490 billion would be spent on diabetes globally. In addition, 
about $1,330 per person was anticipated to spend on diabetes in 2010 (Zhang 2010).  
 
According to the International Diabetes Federation (IDF) (2015), the T2DM epidemic 
influences about 387 million people worldwide in 2014, approximately 46% of those affected 
aged from 40 to 59 years. The total number of people with diabetes will rise steeply to 642 
million by 2040 if no prevention and control strategies are implemented. In 2006, the IDF 
estimated that Eastern Mediterranean and the Middle East were regions with high rates of 
affected people in the world with 9.2% and then followed by North America with 8.4%. 
However, the largest numbers were found in the Western Pacific region, with 67 million 
patients with T2DM, followed by Europe with 53 million diagnosed patients. With respect to 
country, India still leads the global top ten of the highest number of diabetic people with 40.9 
million, followed by China with 39.8 million.  
 
T2DM is a chronic disease and as it progresses, it introduces multi-system complications for 
patients. These complications of the disease produce a tremendous impact on patients and the 
health care system as well. The quality of life is severely reduced when people have T2DM 
accompanied with complications. Both tangible and intangible costs for these patients are 
predicaments not only to families but also to the society. The often seen complications are 
micro-vascular endpoints such as retinopathy, neuropathy and macro-vascular endpoints 




are vulnerable to other diseases. In particular, patients with T2DM are about four times more 
likely to develop CVD than the general population (Barr 2007) and have a five-fold greater 
risk of dying from these conditions (IDF 2015). Apparently, complications of T2DM not only 




Once T2DM was considered as a disease of afluent countries,  but now it has also become a 
public health priority for developing countries. The prevalence rate of T2DM in Asia has 
increased rapidly in the past decade, characterised by young age of onset and low BMI (Chan 
et al. 2009). It was estimated that 387 million people suffering from this disease worldwide in 
2014, of which 213 million reside in Asia (75 million in South East Asia and 138 million in 
Western Pacific). Furthermore, about 3.6 million patients died annually from diabetes related 
causes in this region (IDF 2015).   
 
In Vietnam, epidemiological characteristics of T2DM are little known compared to other 
countries in the Asian region. A recent national survey reported that an overall prevalence rate 
of T2DM in the Vietnamese population was 5.4% in 2012 (National Hospital of Endocrinology 
2012). However, this prevalence is more likely to be underestimated because of the use of 
fasting blood glucose for testing (Wahl et al. 1998). Understanding the risk factors is critical 
for effective prevention and control strategies for T2DM. The etiology of T2DM is 
characterised by the interaction between environmental and genetic factors. While the 
association between T2DM and genetic factors is strong (Hara et al. 2014), other modifiable 




et al. 2009). Unhealthy diets (Ley et al. 2014), physical inactivity (Schellenberg et al. 2013), 
passive and active smoking (Zhu et al. 2014, Willi et al. 2007), and excessive alcohol intake 
(Wei et al. 2000) are common modifiable risk factors for T2DM.  
 
Along with rapid economic growth and urbanisation, Vietnam is one of the Asian countries 
that has experienced dietary changes, including increasing fat andmeat intakes (Khan and Khoi 
2008).  There are also concerns about increasing body size (Ta 2008, Ta et al. 2010, Le et al. 
2005), physical inactivity (Ta 2008, Ta et al. 2010, Le et al. 2004), tobacco smoking (WHO 
2008b), and alcohol overuse (Giang et al. 2008) among Vietnamese adults. Meanwhile, 
increased life expectancy (Hoi et al. 2009) has resulted in a rapid growth in the number of older 
persons, and low health care expenditure (Palmer 2014) are also contributing to a high 
prevalence of T2DM. These changes are all potentially contributing to the accelerating 
prevalence of T2DM in Vietnam. During the past two decades, in this country, a number of 
epidemiological studies on T2DM have been undertaken at both national (National Hospital of 
Endocrinology 2012, Ta 2008, National Hospital of Endocrinology 2002) and regional levels 
(Ta et al. 2010, Quoc et al. 1994, Tran et al. 2012, Pham and Eggleston 2015). Synthesis of 
these epidemiological data can provide a better understanding of the prevalence and trends, 
and suggest solutions to addressing the problem. Therefore, a systematic review of 
epidemiological studies in Vietnam on T2DM was performed to address secular prevalence 
trend and its risk factors.  
 
We performed a systematic literature search through PubMed, Web of Science, Wiley Online 
Library, and Scopus databases in 2 steps. First, we identified relevant publications using the 




hyperglycaemia, Vietnam without any restriction on the type, year, and language of 
publication. Second, we eliminated duplicated articles retrieved from the aforementioned 
databases. In the next stage, we checked the titles and abstracts of each identified article for 
eligibility based on the following selection criteria: 
 
Inclusion criteria 
● Primary data, population-based epidemiological studies 
● Hospital-based studies 
Exclusion criteria 
● Gestational diabetes 
● Type 1 diabetes 
● Latent autoimmune diabetes in adults 
● Letters, commentaries, and editorials 
 
We extended our search to published reports from Web sites of the WHO and IDF. We also 
searched the reference lists of selected articles and recruited relevant articles and national 
reports in Vietnamese, then contacted authors or co-authors to obtain full-text records. Finally, 
the full text of eligible articles and reports were evaluated and synthesized in this review. This 
systematic review was conducted according to the PRISMA guidelines (Moher et al. 2009). 
 
2.2.2 Trend in the prevalence 
Selection procedure 
Figure 2 shows the PRISMA flow diagram of the systematic search. From the total 329 




found to be associated with diabetes in Vietnam after initial screening band excluding 
duplicates. These articles were manually checked by title and abstact, and accordingly 58 
articles were found irrelevant to the inclusion criteria. Of the 18 remaining articles that met the 
selection criteria, we excluded one research letter, one editorial, and 6 non-full text articles. 
Finally, 10 original full text articles were included for this review. 
 
Characteristics of included studies 
Three studies estimated only the prevalence of T2DM (National Hospital of Endocrinology 
2012, 2002, Do and Le 2008), two investigated risk factors (Le et al. 2005, Tran, Phuong, et 
al. 2013), and five addressed both prevalence data and risk factors (Ta 2008, Ta et al. 2010, Le 
et al. 2004, Quoc et al. 1994, Tran et al. 2012). The sample sizes varied from 144 to 11,191 
subjects. The eight studies that estimated the prevalence all used the 1998 WHO diagnostic 
criteria (Alberti and Zimmet 1998), except for one that used the 1985 WHO criteria (WHO 
2008b). One study (Le et al. 2004) recruited subjects aged over 15 years and the remainders 
selected adults aged 30 years and above (National Hospital of Endocrinology 2012, Ta 2008, 
Ta et al. 2010, National Hospital of Endocrinology 2002, Quoc et al. 1994, Tran et al. 2012, 
Do and Le 2008) (Table 1). Risk factors and their odds ratios (ORs) with 95% confidence 
interval (95% CI) for T2DM are presented in Table 2. All selected studies meet the level III of 
evidence which is recommended by the National Health and Medical Research Council of 
Australia (2009). 
 






Figure 2: PRISMA flow diagram for study selection in the systematic review on trends in prevalence and risk 
factors of T2DM in Vietnam (1994-2012) 
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The prevalence of T2DM was estimated regionally and nationally between 1994 and 2012 
(Table 1). Data derived from two national surveys which used the same 1998 WHO criteria 
showed that aged-standardised prevalence rates were 2.7% in 2002 (National Hospital of 
Endocrinology 2002) and 5.4% in 2012 (National Hospital of Endocrinology 2012). The 
prevalence rates of T2DM in the northern region were 1.4% in 1994 (Quoc et al. 1994) and 
3.7% in 2012 (Tran et al. 2012); the corresponding rates in the southern region were 3.8% in 
2004 (Le et al.), 7.0% in 2008 (Do and Le), and 12.4% in 2010 (Ta et al.).     
 
2.2.3 Risk factors 
Demographic factors 
T2DM is a chronic disease that is accelerated by the ageing population. A range of evidence 
showed that increasing prevalence and incidence of T2DM are associated with advancing age 
(WHO 2010b). In Vietnam, the prevalence of T2DM increased with age and the highest 
prevalence was found in subjects of over 65 years old (Le et al. 2004). The association between 
age and T2DM prevalence was examined in two studies (Ta 2008, Le et al. 2004), showing 
that increasing age was positively associated with higher prevalence of T2DM; the OR (95% 
CI) among subjects aged ≥45 relative to under 45 year-old group was 3.5 (2.1 to 5.8) (Ta 2008), 
and the correspondent values among those aged ≥40 versus under 40 year-old group was 3.3 
(1.9 to 5.5) (Le et al. 2004). There was no measurable difference in prevalence of T2DM 
between men and women as reported by the two national surveys (National Hospital of 
Endocrinology 2012, 2002). However, two regional studies revealed that women were more 
likely to have T2DM than men; ORs (95%CI) were 2.3 (1.3 to 4.1) in an earlier study (Quoc 




Table 1: Prevalence of T2DM in Vietnam: a systematic review 1994-2014 




(95% CI) Diagnostic criteria 
Quoc, Chartles et al. 1994 






4,912 1.4 (0.9 to 1.8) 
(adjusted, M/F: 0.7/1.8) 
 WHO1985: 2h-OGTT ≥11.1 mmol/l OR 
Fasting capillary blood glucose ≥6.7 mmol/l 
(whole blood) OR self-report 
National Hospital of 
Endocrinology 2002 
(National Hospital of 
Endocrinology 2002)* 
Nationwide 30-64 Survey 9,122 2.7 (2.4 to 3.1) 
(adjusted†) 
WHO1998: Fasting plasma glucose≥7mmol 
OR 2h-OGTT ≥11.1mmol/l 
Le et al.2004 
(Le et al. 2004) 
South 
(Ho Chi Minh City) 
>15 Cross-
sectional 
2932 3.8 (3.5 to 4.1) 
(adjusted†) 
WHO1998/ADA1997: Fasting plasma 
glucose≥7mmol/l OR using hypoglycaemic 
treatment OR self-report 
Do and Le 2008 
(Do and Le 2008) * 
South 
(Ho Chi Minh City) 
30-69 Cross-
sectional 
1,456 7.0 (5.7 to 8.4) 
(crude, M/F: 8.2/5.5) 
WHO1998: Fasting plasma glucose ≥7mmol 
OR 2h-OGTT ≥11.1mmol/l OR self-report 
Ta 2008 
(Ta 2008)* 
4 major cities 





2,394 4.0 (3.3 to 4.9) 
(adjusted, M/F: 6.0/5.2) 
WHO1998: Fasting plasma glucose ≥7mmol 
OR 2h-OGTT ≥11.1mmol/l 
Ta, Nguyen et al. 2010 
(Ta et al. 2010) 
South 
(Ho Chi Minh City) 
30-72 Cross-
sectional 
2,142 12.4 (11.0 to 13.8) 
(crude, M/F: 10.8/11.7) 
WHO1998: Fasting plasma glucose ≥7mmol 
OR 2h-OGTT ≥11.1mmol/l 
Tran, Phuong et al. 2012 





2,710 3.7 (2.7 to 4.7) 
(adjusted, M/F: 4.6/2.9) 
WHO1998: Fasting plasma glucose ≥7mmol 
OR 2h-OGTT ≥11.1mmol/l OR self-report 
National Hospital of 
Endocrinology 2012 
(National Hospital of 
Endocrinology 2012)* 
Nationwide 30-69 Survey 11,191 5.4 (4.8 to 6.0) 
(adjusted, M/F: 6.0/5.4)  
WHO1998: Fasting plasma glucose ≥7mmol 
OR 2h-OGTT ≥11.1mmol/l 
*Articles are in Vietnamese.  
† No sex-specific prevalence rate.  




In addition, the present review indicated that urban residents were more likely to have T2DM 
than their rural counterparts; OR (95%CI) for T2DM were 1.3 (1.0 to3.2) (Quoc et al. 1994) 
and the prevalence of T2DM in urban and rural populations were 4.4% and 2.3%, respectively 
(National Hospital of Endocrinology 2002). 
 
Anthropometric parameters 
Anthropometric features of T2DM vary between countries and races. Anthropometric factors 
reviewed in this chapter are BMI and waist-hip ratio (WHR). Amongst the five articles 
retrieved for Vietnam, there was only one article mentioning central obesity (Ta et al. 2010). 
The authors stated that the risk of having T2DM was increased by 6.4-fold (95%CI 3.2 to 13.0) 
in males and 4.1-fold (95%CI 2.2 to 7.6) in females when comparing between central obesity 
group and non-central obesity group. They also reported that higher WHR and hypertension 
were independently associated with elevated risk of T2DM. Another study similarly indicated 
that lower BMI values should be used for classifying overweight and obesity to evaluate the 
risk of T2DM in Vietnam (Duc et al. 2005).  
 
BMI is commonly used to identify and classify overweight and obesity in epidemiological 
studies. However, the index may not be appropriate to all races in the world to study T2DM 
risk. Western and Asian people do not share the same cut-off values of BMI in the classification 
of overweight and obesity (Barba 2004). The WHO (2004) has approved new criteria for 
classifying overweight and obesity applicable to Asians. BMI cut-off values for Asians were 
lower than those of Caucasians in evaluating T2DM risk. For instance, a review of 
anthropometric characteristics in Vietnam suggested that lower cut-off values of BMI and 
WHR (0.90 for males and 0.85 for females) should be applied to T2DM related studies in 




In addition, this study also indicated that central obesity and percent body fat of Vietnamese 
people seemed to be higher than Caucasians. If these results are reliable, the new cut-off value 
of BMI will have significant implications for primary prevention and future interventions in 
Vietnam. A recent extensive study in China showed that even amongst the T2DM group, their 
mean BMI was observed to be lower than 18. Namely, there was a T2DM prevalence of 4.5% 
in Chinese people with a BMI of less than 18 kg/m2 (Cheng 2010), which raises concerns about 
the effectiveness of the use of BMI values in the classification of overweight and obesity. 
Although BMI is a practical measure, being a crude measure, it could not distinguish between 
fat mass and lean mass and may underestimate T2DM risk among Asian people. A recent study 
suggested that a percent body fat >30 in men or percent body fat >40 in women should be used 
as diagnostic criteria for obesity in Vietnamese adults (Ho-Pham et al. 2015). 
 
Indicators of abdominal adiposity such as waist circumference, WHR and waist-height ratio, 
are alternatives to BMI to predict the risk of CVD and T2DM(WHO 2008a). These 
measurements aim to reflect visceral adipose tissue associated with a range of metabolic 
disorders that increase the risk of T2DM. A range of evidence in the last three decades has 
indicated a positive association between obesity and the risk of developing T2DM based on 
both cross-sectional studies (Hartz et al. 1983, Skarfors, Selinus, and Lithell 1991, Shaten et 
al. 1993) and cohort studies (Ohlson et al. 1985, Cassano et al. 1992). 
 
In our systematic review (Table 3), two studies showed a significantly higher odds of T2DM 
among overweight subjects compared with their normal-weight counterparts; ORs (95% CI) 
were 2.6 (1.6 to 4.0) (Ta 2008) and 1.6 (1.1 to 2.0) (Le et al. 2004) using a cut-off point of ≥23 
and ≥25 (kg/m2), respectively. Of four studies presenting WHR, three reported a positive 




studies found a significantly positive association between percent body fat determined by the 
bioelectrical impedance analysis (BIA) and T2DM prevalence; ORs (95%CI) per one unit 
increase in body fat were 1.0 (1.0 to 1.1) (Tran et al. 2012) and 1.5 (1.2 to 1.7) (Le et al. 2005). 
The prevalence of T2DM also increased as abdominal fat increased; ORs (95%CI) per 1 
standard deviation increment (4 kg) in abdominal fat among men and women were 1.7 (1.3 to 
2.2) and 1.5 (1.3 to 1.8) (Ta et al. 2010), respectively, see Table 2.  
 
These studies also suggested the consistency of relationship across the adulthood populations, 
in spite of differences in measurement methods of fatness and diagnostic criteria for T2DM, 
which reflects the strength of the association. Obviously, the risk factor of T2DM increases 
with increasing obesity. Many analyses of this association between obesity and onset of T2DM 
in adults have confirmed that abdominal obesity is an important risk for T2DM after controlling 
for age, smoking, and family history of diabetes. Since BMI correlates less closely with 
abdominal adipose tissue than waist circumference, indicators such as waist circumference and 
WHR have been the topic of T2DM study for the last 30 years.  
 
A recent review revealed that anthropometric measures such as BMI, waist circumference, 
WHR and waist-height ratio were similar for predicting the risk of T2DM (Qiao and Nyamdorj 
2010). However, most of these studies mentioned above employed a cross-sectional design and 
suggested that waist circumference and WHR may be more effective predictors than BMI. 
Although the evidence is neither totally convincing nor generalisable, these measures are still 
potentially useful towards estimating the risk of T2DM.  
 
The main methodological issues that influence the ability to draw clear conclusions by 




studies utilised the sensitivity and specificity approach to determine the optimal cut-off values 
for anthropometric-related measures. However, the selection of these cut-off values appears to 
be arbitrary, because there is a trade-off between sensitivity and specificity. In reality, the high 
sensitivity of waist circumference measurement may be preferred in health promotion for the 
purpose of raising awareness of the public; whereas the high specificity of waist circumference 
is expected in diagnosing T2DM in clinical practice. Thus, the role of waist circumference as 
an initial diagnostic tool of T2DM is still unclear (Zimmet, Alberti, and Shaw 2001). Further 
cohort studies with incident cases of T2DM are required to make clearer recommendations for 
the use of waist circumference.  
 
The review by Qiao & Nyamdorj (2010) suggested that the optimal cut-off points for obesity 
and waist circumference vary across different populations and countries. Waist circumference, 
WHR, and BMI cut-off values should be flexibly applied to various populations. According to 
the WHO (2008a), a wide range of associations were apparent between anthropometric 
measures and risk of T2DM; hence, it would be difficult to conclude that measures of 
abdominal adipose obesity are always superior to BMI in predicting the risk of T2DM.  
Table 2: IDF criteria for ethnic or country-specific values for waist circumference 

















Table 3: Risk factors of T2DM in Vietnam 
Source Study design Sample size Year(locations) Risk factors 
Tran, Phuong et al.2013 







Tran, Phuong et al.2012 
(Tran et al. 2012) Cross-sectional 2,710 
2012 
(Hanam province) 
WHR: adjusted OR=1.5(95%CI1.2 to 1.9) 
Percent body fat: adjusted OR=1.0(95%CI1.0 to 1.1) 
Family history: adjusted OR=4.4(95%CI2.2 to 8.7) 
Hypertension: adjusted OR=1.7(95%CI1.1 to 2.7) 
Ta, Nguyen et al. 




(Ho Chi Minh City) 
WHR (per0.07increase): adjusted OR=2.5(95%CI1.8 to 3.5) in women and 
1.7(95%CI1.4 to 2.0) in men. 
Central adiposity (per4kgincrease): OR=1.7(95%CI1.3 to 2.2) in men and 
1.5(95%CI1.3 to 1.8) in women 
Systolic blood pressure (per20mmHgincrease): OR=1.4(95%CI1.1 to 1.7) 
inmenand1.5 (95%CI1.2 to 1.5) in women. 




(Hanoi, Ho Chi 
Minh, Danang and 
Haiphong) 
Age≥45:OR=3.5(95%CI2.1 to 5.8) 
BMI≥23:OR=2.6(95%CI1.6 to 4.0) 
Family history: OR=3.5(95%CI2.0 to 5.6) 
Hypertension: OR=2.0(95%CI1.3 to 3.0) 
Light physical activity (moderate and vigorous PA as 
reference):OR=1.6(95%CI1.0 to 2.5) 
Le, Hanhetal. 






(Ho Chi Minh City) 
WHR: adjusted OR=1.0(95%CI0.8 to 1.5) 
Percent body fat: adjusted OR=1.5(95%CI1.2 to 1.7) 
Animal protein intake: adjusted OR=1.2(95%CI1.1 to 1.3) 
Leetal.2004 
(Le et al. 2004) Cross-sectional 2,932 
2004 
(Ho Chi Minh City) 
Age≥40:OR=3.3(95%CI1.9 to 5.5) 
Sex (male as reference):OR=1.8(95%CI1.2 to 2.8) 
WHR (normal WHR as reference):OR=2.6(95%CI1.9 to 3.6) 
Overweight (BMI≥25):OR=1.5(95%CI1.1 to 2.0) 
Having a large for gestational age baby: OR=2.7(95%CI1.6 to 4.4) 
Light physical activity (heavy PA as reference):OR=2.2(95%CI1.2 to 4.2) 




Cross-sectional 4,912 1994 (Hanoi City) 
 
Sex (male as reference): RR=2.3(95%CI1.3 to 4.1) 
Locality (rural as reference): RR=1.3(95%CI1.0 to 3.2) 
 
 





It is well known that T2DM is in part, inherited. Many studies have confirmed that people 
whose first-degree relatives have T2DM were approximately three times more likely to develop 
the disease than those without any family history (Florez, Hirschhorn, and Altshuler 2003, 
Gloyn 2003, Hansen 2003). Some twin studies also found that concordance rates for 
monozygotic twins are considerably higher than those among dizygotic twins (Gale et al. 
2001). Therefore, there is a strong association between the genetic factor and T2DM risk.   
 
Based on the epidemiological evidence of genetic-related T2DM, one approach is to identify 
candidate genes (Barroso et al. 2003, Stumvoll 2004). Candidate genes are selected mostly 
based on the relationship between pancreatic functions and metabolic disorders. About 50 
candidate genes are being studied in various populations. However, research findings remain 
conflicting. Amongst these genes, some promising candidates are PPARy (RR, 1 to 3), ABCC8 
(RR, 2 to 4), KCNJ11 (RR, 1 to 2), and CALPN10 (RR, 1 to 4). Small sample sizes, different 
susceptibility across ethnic populations, variation in environmental exposures, and gene-
environmental interactions are the possible explanations for the discrepancies. Our systematic 
review found cross-sectional studies in Vietnam also indicated that family history of diabetes 
(Ta et al. 2010) and genetic factor (FTO-rs9939609 polymorphism) (Tran et al. 2012) were 
related to an increased likelihood of T2DM. 
 
Gestational diabetes mellitus 
According to the WHO (2011), gestational diabetes mellitus (GDM) refers to a hyperglycaemia 
with onset or first recognition during pregnancy. GDM is most often diagnosed through 
prenatal screening. A review study (Bellamy et al. 2009) concluded that women with 
gestational diabetes during their pregnancy had an increased risk of developing T2DM 




compared with those who had a normoglycaemic pregnancy (RR 7.4, 95% CI 4.7 to 11.5). 
Lauenborg et al. (2009) concluded that GDM and T2DM were positively associated. 
 
In Vietnam, little is known about the association between GDM and risk of T2DM. However, 
a study carried out in Australia (Henry et al. 1993) on Vietnam-born women found that their 
incidence of T2DM (7.8%) was higher than those of Australian with GDM (4.3%), which 
deserves further investigation on GDM and T2DM risk in the future.  
 
Dietary factors 
Diet plays a vital role in human health. However, over-consumption of food may lead to 
excessive energy intake and result in overweight and obesity (Allison and Mattes 2009), which 
is closely associated with the onset of T2DM (Smyth and Heron 2006). Furthermore, high 
dense energy foods or beverages with high sugar content are known to increase the risk of 
T2DM and CVD (Ventura, Davis, and Goran 2011, Imamura et al. 2015). Fast foods and 
processed foods have been increasingly consumed worldwide. Low and middle-income 
countries usually have traditional dietary patterns that provide healthy foods for people, but 
now they are facing the nutritional transition and changes of food choices (Hu 2011).  
 
People living in urban areas tend to consume more fast foods because of convenience and time 
saving. Vietnam is a low and middle-income country experiencing a nutrition transition 
(Khan and Khoi 2008). The dietary pattern has been also changed from healthy traditional 
pattern to an unhealthy pattern. It could be associated with the higher T2DM prevalence, which 
has been reported recently in the central cities. In a systematic review found a small case-
control study (n=144) conducted in southern Vietnam reported that animal protein intake was 
positively associated with the risk of T2DM (Le et al. 2005). For low-resource countries, 




investigation of traditional dietary factors, which may be protective factors for T2DM is 
essential. 
 
Consumption of single dietary components such as nutrients or foods has been shown favorably 
associated with prevention of T2DM. For example, fruit and vegetables, creal fiber, moderate 
alcohol, tea, coffee, low-fat dairy may reduce the risk of developing T2DM in human (Jiang, 
Zhang, and Jiang 2014, Mamluk et al. 2016, Yang, Wang, et al. 2014, Kastorini and 
Panagiotakos 2009). Selected nutrients contained in dietary or food components have been 
observed related to T2DM because they may affect glucose and insulin metabolism (Bantle et 
al. 2008). However, little convincing data documents their roles in the development of T2DM. 
Therefore, dietary-patterning analysis has been used as an alternative method to single nutrient 
approach because it can evaluate cumulative effects of the overall diet. 
 
Hypertension 
Hypertension and diabetes are the leading risk factors for atherosclerosis, heart attacks, and 
strokes. Their etiology and disease mechanisms may have shared characteristics. In the US 
population, hypertension presents in about 30% of type 1 diabetic patients and in 50% to 80% 
of type 2 diabetic patients (Landsberg and Molitch 2004). Another prospective cohort study in 
the United States claimed that T2DM was almost 2.5 times as likely to develop in hypertensive 
subjects as in subjects with normal blood pressure (Gress et al. 2000). In the Hong Kong 
Cardiovascular Risk Factor Prevalence Study, only 56% of people with hypertension had 
normal glucose tolerance and only 42% of people with diabetes had normal blood pressure 
(Cheung 2010). Hypertension and diabetes and are found in the same individual more often 
than would occur by chance (Cheung et al. 2008). This may suggest that either shared genetic 
or environmental factors in the etiology (Cheung 2010). 





Studies (Everett, Frithsen, and Player 2011, Sheng and Sun 2011) have indicated that the use 
of anti-hypertension medication may increase the risk of T2DM. However, others claimed that 
the risk of T2DM is not significantly different between the used and the non-used (Gress et al. 
2000). For instance, treatment of thiazide did not increase the risk of T2DM. After controlling 
for confounders including age, sex, race, and use of other antihypertensive medications, 
hypertensive patients who were taking thiazide diuretics were not at a higher risk of developing 
T2DM than those not taking the medicine (relative hazard 0.91, 95%CI 0.7 to 1.1) (Gress et al. 
2000). Gress et al. (2000) also observed that subjects who took angiotensin-converting–enzyme 
inhibitors and calcium-channel antagonists were not at higher risk than others in the placebo 
group. On the contrary, hypertensive subjects who took beta-blockers had a 28% increased risk 
of subsequent T2DM (Gress et al. 2000). 
 
Cohort and randomised controlled trials have suggested that T2DM incidence is unchanged or 
increased by thiazide diuretics and beta blockers (Padwal and Laupacis 2004). In addition, 
ACE inhibitors, calcium channel blockers and angiotensin receptor blockers seem not to affect 
the T2DM incidence (Padwal and Laupacis 2004). The findings of recent studies are still 
inconsistent regarding antihypertensive medications and risk of T2DM (Helgeland 1980, 
Neaton et al. 1993, Berglund, Andersson, and Widgren 1986). Ta et al showed that elevated 
systolic blood pressure (OR 1.4, 95%CI 1.1 to 1.7) (Ta et al. 2010) and hypertension (OR 2.0, 
95%CI 1.3 to 3.0) (Ta 2008) were positively associated with T2DM prevalence in Vietnam. 
Cigarette smoking 
Cigarette smoking has been established as an independent risk factor for developing T2DM. A 
prospective cohort study of 7,124 men with no history of diabetes, coronary heart disease, or 
stroke at the baseline, found that cigarette smoking was associated with a significant increase 




in T2DM risk, after adjustment for age, BMI, and other potential confounding factors. The 
benefit of giving up smoking was apparent after five years of smoking cessation, and risk 
reverted to that of never-smokers only after 20 years. The risk of T2DM amongst those who 
switched from smoking cigarettes to pipe or cigars remained similar to the risk of continuing 
cigarette smokers. Men who quit smoking during the first five years of follow-up showed 
significant weight gain and subsequently higher risk of T2DM than continuing smokers 
(Wannamethee, Shaper, and Perry 2001). Recent meta-analyses revealed an increased risk in 
new quitters when compared with never smokers; however, the risk reduced substantially after 
five and ten years since quitting (Pham et al. 2015, Pan et al. 2015). 
 
Another prospective cohort study conducted on Japanese males from 1984 to 1992 found that 
the risk of developing T2DM increased three times among those who smoked 16-25 cigarettes 
a day than those who never smoked, after controlling for other risk factors such as alcohol 
consumption and obesity (Kawakami et al. 1997). Furthermore, the study also indicated that 
the risk was considerably higher among those who started smoking at the age of 18, or before, 
in comparison to never-smokers after controlling for age. Another follow-up study on Japanese 
males (n=1,266) between 1994 and 1999 estimated that the level of consumption and the 
number of years of smoking were positively correlated with the development of T2DM as well 
as impaired fasting glucose (Nakanishi et al. 2000). A study of male physicians in the USA 
(n=21,068) also established that cigarette smoking was an independent risk factor for 
developing T2DM. Current smokers who smoked 20 cigarettes a day showed an RR of 1.7 
(95%CI 1.3 to 2.3) when compared with those who never smoked, after controlling BMI, 
physical activity, and other confounding factors such as medical history and alcohol 
consumption. Similarly, current smokers of over 20 cigarettes per day (RR 1.5, 95%CI 1.0 to 
2.2) and past smokers (RR 1.1, 95%CI 1.0 to 1.4) also had increased risks of developing T2DM 




when compared to never-smokers, though elevated risk was not as high as the heavy smokers 
(Manson et al. 2000). A 17-year prospective cohort study conducted in the UK (n=7,735) found 
cigarette smoking was significantly associated with the risk of T2DM independent of age, BMI, 
and other confounding factors. Furthermore, this study also indicated that cigarette smoking 
was an independent risk factor for T2DM among light smokers (less than 20 cigarettes per day) 
as well as heavy smokers (20 or more cigarettes per day). However, a dose-dependent 
association was not established (Wannamethee, Shaper, and Perry 2001). 
 
More recent studies have found a dose-response relationship between T2DM and cigarette 
smoking. A meta-analysis of 25 studies reported that when compared to never-smokers, the 
RR of T2DM was greatest for current heavy smokers (RR 1.61, 95%CI 1.43 to 1.80), followed 
by current light smokers (RR 1.29, 95%CI 1.13 to 1.48), with the least risk in the former smoker 
group (RR 1.23, 95%CI 1.14 to 1.33) (Willi et al. 2007). However, the authors concluded that 
a causal relationship between smoking and the development of T2DM still could not be 
established, because the influence of mediating factors such as stress levels, diet, and physical 
activity levels are not yet fully understood (Tonstad 2009). No information on the association 
between cigarettes smoking and T2DM risk was found in a recent systematic review in 
Vietnam.  
 
2.3 Popular beverages 
2.3.1 Tea consumption 
Tea is the second most commonly consumed beverage in the world, after water. Tea, including 
green tea, black tea and oolong tea, is derived from the leaves of the plant called Camellia 
sinensis (Graham 1992), of which green tea is the dominant type in Asian countries including 
Vietnam (Sun et al. 2007). Tea, particularly green tea, is rich in polyphenolic compounds 




(Zaveri 2006) as principal active ingredients to protect against oxidative damage and increase 
insulin sensitivity (Brown et al. 2009, Pham et al. 2014), suggesting a beneficial role of tea 
consumption against T2DM. Experimental studies in animals have demonstrated reduction of 
oxidative stress and the anti-diabetic activity of green tea extracts (Sabu and Kuttan 2002, 
Hininger-Favier et al. 2009). The predominant active component is likely to be 
epigallocatechin gallate (EGCG) in green tea extracts, which increased uptake of blood glucose 
by rat adipocytes regardless of the presence or absence of added insulin (Anderson and 
Polansky 2002). 
 
Several epidemiological studies have been undertaken to examine the association between 
habitual tea consumption and T2DM (Greenberg et al. 2005a, Song et al. 2005, Odegaard et al. 
2008, van Dieren et al. 2009, Iso et al. 2006), but their results are not entirely consistent (Oba 
et al. 2010, Panagiotakos et al. 2009). A large prospective cohort study of 1,440 adults in Japan 
showed an inverse association between green tea consumption and T2DM risk (Pham et al. 
2014) whereas another study in Singapore found no association (Odegaard et al. 2008). The 
follow-up of the Singaporean study was less than six years, which may underestimate the 
association between green tea and risk of T2DM. In addition, only 12% of participants reported 
that they drank at least one cup of black or green tea per day while 71% of participants reported 
drinking coffee more than one cup per day. Therefore, the coffee was commonly consumed but 
not green tea in this study. A recent meta-analysis (Yang, Mao, et al. 2014) confirmed that 
drinking ≥ 3 cups of tea daily was associated with reduced risk of T2DM, 16% reduction for 
Asian people, but only 3% for Europeans. The meta-analysis study also provided a systematic 
review of current cohort studies related to tea consumption and T2DM risk, but it was unable 
to conduct stratified analysis for different tea types, and most of the included studies did not 
adjust for coffee intake which may confound the association. Albeit epidemiological studies 




have provided evidence for the protective role of tea consumption against T2DM in Asian 
people, few studies have addressed the role of tea in T2DM in this region, particularly green 
tea (Sun et al. 2007, Iso et al. 2006). A clinical trial observed that tea intake was associated 
with lower blood glucose levels (Hosoda et al. 2003), but the hypoglycaemic effect of green 
tea on diabetic patients was not consistent with another study (MacKenzie, Leary, and Brooks 
2007). The inconsistency may be explained by the short duration of trials, different doses of 
tea consumption and various types of tea. Green tea has been incorporated in functional foods, 
which are conceivably preferable to drugs for prevention and control of T2DM in Asia. 
However, to promote tea consumption for people as a beneficial beverage against T2DM needs 
more reliable evidence from future studies.  
 
Given the increasing prevalence of T2DM in Vietnam, it is imperative to elucidate whether 
green tea consumption as a daily beverage may offer some protection against this disease. The 
present case-control study aimed to investigate the association between habitual green tea 
consumption and T2DM risk among Vietnamese adults. 
 
2.3.2 Coffee consumption 
Similar to tea, coffee is one of the most common beverages in the world, particularly in the 
Western population. A prospective cohort study (n=17,111) reported that coffee consumption 
may be associated with a reduced risk of T2DM (van Dam and Feskens 2002). This finding 
was supported by a similar cohort study in Japan (n=1,916 men and 2,704 women) (Isogawa 
et al. 2003), whereas no protective effect was seen in one cohort study among the Finnish 
people (n=19,518 men and women) (Reunanen, Heliovaara, and Aho 2003) and one American 
study (n=2,680) (Saremi, Tulloch-Reid, and Knowler 2003). Whether coffee consumption is 
associated with a reduced risk of T2DM thus seems to be unclear. A systematic review of 




"adding number of included studies" prospective studies conducted in mainly Western 
countries between 1966 and 2009 stated that every additional cup of coffee consumed daily 
was associated with a 7% decrease in the risk of T2DM (RR 0.93, 95%CI 0.91 to 0.95) after 
controlling for potential confounders (Huxley et al. 2009). This review also reported that only 
20% of the studies were conducted in non-white populations, which fairly restricted the 
findings to mainly Western populations.  
 
Components in coffee that may have beneficial effects on glucose tolerance have been 
indicated recently. For example, magnesium and chlorogenic acid may improve on insulin 
sensitivity (Salmeron et al. 1997, Khan et al. 1998) and caffeine may be beneficial with regard 
to beta-cell function (Shi 1997). In addition, magnesium may also improve b-cell function 
(Paolisso et al. 1992). Moreover, studies on caffeine have shown that this compound can 
improve insulin sensitivity (Reunanen, Heliovaara, and Aho 2003), but its opposite action has 
also been reported (Keijzers et al. 2002).  
 
Little information has been found in the literature with regard to the association between coffee 
consumption and T2DM in Vietnam, the second largest coffee beans exporting country in the 
world (Food and Agricultural Organisation 2016). To our best of knowledge, none of the 
observational studies were conducted to investigate the association between coffee 
consumption and T2DM in Vietnam. Therefore, to mitigate the negative effect of the T2DM 
epidemic, protective dietary factors should be investigated particularly daily beverages such as 
tea and coffee.  
 




2.4 Physical activity 
Physical activity plays a significant role in the aetiology of several metabolic diseases, 
including T2DM. It is well known that the intensity of physical activity is more important than 
having exercise. The intensity of activities is assigned an intensity level based on the rate of 
energy expenditure expressed as metabolic equivalent tasks (METs). According to the updated 
Compendium of Physical Activities (Ainsworth et al. 2000), there are 21 major headings 
including 605 specific physical activities assigned to different levels of intensity. In 
observational epidemiologic studies, the classification for physical activity by three levels, 
namely, light (<3 METs), moderate (3-6 METs), and vigorous activity (>6 METs) has been 
commonly used. Moderate to vigorous physical activity have been reported to delay or reduce 
the onset of T2DM (Hayes and Kriska 2008) whilst light physical activity appears to have little 
effect (Zhang et al. 2010). In addition, a review of 10 cohort studies, including more than 
300,000 participants and 9,367 incident T2DM cases, indicated that the average RR of T2DM 
was 0.69 (95%CI 0.58 to 0.83) for regular physical activity of moderate intensity when 
compared to being sedentary (Jeon et al. 2007). Regular physical activity with moderate or 
vigorous intensity is likely to be protective against T2DM (Blair 2009). The findings of our 
systematic review indicated that there was a cross-sectional study conducted in Ho Chi Minh 
city reporting that light physical activity and sedentary behaviour were positively associated 
with T2DM prevalence in Vietnam (Le et al. 2004). A recent national estimate for physical 
activity level in Vietnam reported that around seven-in-ten Vietnamese people aged 25–64 
years met the WHO recommendations for total physical activity, which was mainly derived 
from work activities and higher in rural areas (Van Bui et al. 2015). Despite the emerging 
evidence of physical activity for T2DM, little information has been available from Vietnam 
where the trend in prevalence of this disease has increased sustainably in the last two decades. 




From the public health point of view, exploring the association between physical activity and 
T2DM risk is important for the control and prevention of T2DM. 
 
2.5 Summary of literature review 
In this literature review, epidemiological characteristics of T2DM are presented, mainly 
focusing on the prevalence of T2DM and its associated factors in Vietnam. Evidence in the few 
observational studies suggested that older age, urban residence, overweight, increased central 
adiposity, and physical inactivity are probably responsible for the epidemic. In addition, the 
study showed that family history of diabetes, genetic factors, hypertension, and high intake of 
animal protein may contribute to the accelerated T2DM prevalence. Investigation of dietary 
factors and lifestyle is vital for T2DM prevention, especially since the prevalence of T2DM 
has increased two-fold from 2.7% in 2002 to 5.4% in 2012 (Nguyen et al. 2015). The traditional 
beverage, green tea, may offer protection against T2DM, as about 70% of the population 
consume green tea daily. Furthermore, coffee, increasingly consumed in Vietnam, deserves an 
examination with regard to its role for T2DM development. Habitual physical activity is also 
an interesting factor need to be investigated for T2DM risk among Vietnamese adults. 
Protective factors of T2DM, such as tea and coffee consumption and physical activity, which 
are modifiable, can be promoted to the population for better T2DM prevention and control. 
Therefore, we conducted a case-control study in order to investigate the role of these factors 
for T2DM in Vietnam.  








Lifestyle and diet are important determinants of T2DM. It has been suggested that tea and 
coffee consumption, and physical activity are beneficial to health. Their impact on the 
development of T2DM can be evaluated using clinical and epidemiological approaches. 
Randomised controlled trials are the most rigorous design, but would be ethically impossible; 
prospective cohort studies are ranked highest in the hierarchy of epidemiological evidence 
despite being expensive, time-consuming, and less powerful for populations with low 
prevalence of the disease. In resource-limited settings, case-control studies are considered an 
appropriate design. The present hospital-based case-control study was used to investigate the 
association between tea and coffee consumption, and physical activity and T2DM risk among 
adults in Vietnam. Some materials presented in this chapter have been published in the journal 
article (Nguyen et al. 2016).   
 
3.2 Methodology 
3.2.1 Study design 
This study included T2DM cases frequency matched to controls by age and sex on a 1:1 ratio 
in a hospital in northern Vietnam. Data were obtained by interviewing patients with and without 
T2DM. Medical records of eligible cases and controls were searched for laboratory test results 
and medical history information.  
 




3.2.2 Setting and location 
The case-control study was undertaken in Thanh Nhan Hospital located in the catchment 
covering both rural and urban areas of Hanoi City, Vietnam. The period of the study was from 
8/2013 to 10/2015. This is a general hospital comprising 600 beds, 39 departments/units, and 
853 employees. In 2009, there were 317,343 individuals seeking medical care in this hospital, 
with nearly 50% being inpatients. In addition, about 5,000 diabetic patients are being monitored 
and managed in their outpatient department. On average, 30-40 cases of T2DM patients are 
newly diagnosed every month, which would allow recruiting adequate sample size for this 
study within the target time frame. 
 
3.2.3 Sample size calculation 
Our primary objective was to test for the association between green tea consumption, a 
favourite beverage in Vietnam, and the risk of T2DM, and therefore, we used this exposure to 
estimate the required sample size. We implemented frequency-matched sets of cases and 
controls with one matched control per case. Available data indicated that the proportion of 
individuals consuming 1-4 cups of green tea per week (1 cup ~ 200 mL) among controls is 0.7 
(unpublished data). We postulated that the odds ratio for T2DM in subjects drinking 1-6 cups 
of green tea per week relative to non-consumers would be 0.66 (Iso et al. 2006). We need to 
recruit 544 T2DM patients and 544 non-T2DM patients to be able to reject the null hypothesis 
(OR=1.0) with a statistical power of 90% at 5% level of significance (Lwanga SK 1991). In 
practice, to further account for potential refusal and withdrawal, 1200 subjects (600 cases and 
600 controls) were recruited. 
 




3.2.4 Outcome and exposure measures 
Selection of cases 
T2DM cases were identified by searching the medical records of the Department of 
Endocrinology. The hospital uses the 2006 WHO diagnostic criteria for T2DM (WHO 2006). 
We interviewed participants from consecutive patients when they came for treatment. Potential 
participants were asked to take part in the study if they could voluntarily provide inform 
consent. An appointment was arranged for personal interview to obtain information if the 
patient met the selection criteria and agreed to participate.  
Inclusion and exclusion criteria 
Eligibility: Age: 40-65 years 
Matching: cases and controls were frequency matched by age group and gender.  
Inclusion criteria for cases 
- Patients with T2DM diagnosed within 4 weeks before the interview; 
- Diagnoses were based on levels of fasting plasma glucose and/or 2h-OGTT by WHO 
criteria 2006; and 
- Being able to undertake a 40-minute face-to-face interview including measurements. 
Exclusion criteria for cases 
- Patients deemed too ill to participate;  
- Diagnosed with T2DM more than 4 weeks before the interview; 
- In long-term modification of diet due to any reason; and 
- Non-residents. 
 
Selection of controls 
Controls were selected from individuals seeking medical care in an outpatient department of 
the hospital. A control, being frequency-matched to a case on sex and age (±3 years) was 




recruited on the same day using the cumulative distributions of age and gender variables of the 
case and control groups. Diabetic-free status among controls was verified by checking results 
of plasma glucose in medical records. The overnight fasting blood test was routinely conducted 
in the morning at the hospital. If an eligible control consented to participate in the study, s/he 
was then interviewed using the same questionnaire as the cases.  
Inclusion criteria for controls 
- Individuals who attend the hospital outpatient clinics due to minor health problems; 
- Plasma glucose levels in medical records at the normal range based on the WHO diagnostic 
criteria 2006; and 
- At the same age group as cases (± 3 years). 
Exclusion criteria for controls 
- Non-diabetic patients with malignant cancers; 
- Outside the desired age range; 
- In long term modification of diet due to any reason; 
- Non-residents, tourists or foreigners; and 
- Deemed too ill to participate as determined by their medical doctors. 
 
Data collection tools 
A structured questionnaire was used for the face-to-face interview, see Appendix B. This 
questionnaire comprised two sections related to lifestyle information and dietary intake. 
Questions about lifestyle factors, including physical activity, smoking and alcohol drinking, 
were developed in reference to the literature. Habitual physical activity was adapted from a 
validated International Physical Activity Questionnaire-Short Form (IPAQ-SF) for Vietnamese 
adults (Tran, Lee, et al. 2013), while the questions on smoking and alcohol drinking were based 
on the WHO STEPwise approach to non-communicable disease risk factor surveillance 




(STEPS) (WHO 2008b). Dietary intake was assessed using a validated food frequency 
questionnaire for Vietnamese adults (Tran, Van Hoang, et al. 2013). Clinical and biochemical 
outcomes such as blood pressure, pulse rate, triglycerides, low density lipoprotein cholesterol 
(LDLC) and high density lipoprotein cholesterol (HDLC) and total cholesterol, were abstracted 
from medical records. Anthropometric measurements, including height, body weight, waist and 
hip circumferences, were measured using a standard protocol through the instruments, 
including a digital electronic weighing scale (Tanita BC-601), a plastic tape measure, and a 
height stadiometer bar. The percent body fat and adiposity levels were measured by BIA (Kyle 
et al. 2004).  
 
Description of variables 
The outcome variable is dichotomous, i.e., presence or absence of T2DM. Major exposures are 
green tea and coffee consumption, and physical activity. In addition, dietary energy intake (kcal 
per day) and lifestyle factors (smoking, alcohol drinking) are also examined. Additional 
confounding variables and measurement taken included in this study such as demographic 
information (age, sex, marital status, occupation, and education level), clinical data (systolic 
and diastolic blood pressure, pulse rate), biomarkers (fasting plasma glucose, 2h-OGTT, lipid 
profile, plasma uric acid), and anthropometrics (height, weight, waist, hip circumference). 
 
Assessment of physical activity 
Sedentary time was defined as time spent in sitting at home (using computers, watching TV, 
eating meals, and reading newspapers/books), travelling (sitting on motorbikes, in vehicles or 
trains), and sitting in the workplace. Habitual physical activities before the onset of T2DM 
including strenuous sports, vigorous activity, and moderate activity were documented. The 
intensity of each type of physical activity was determined in terms of MET value (Ainsworth 




et al. 2000) and expressed as a sum of MET multiplied by time (hour) spent in each activity 
per week. Lifelong physical activity involvement was defined as doing active sports or 
vigorous exercise or work long enough to get sweaty, at least twice a week. We categorised 
lifelong activity into 3 levels; “never been much involved in physical activity”, “intermittently 
active”, and “always been involved”. 
 
Other lifestyle factors 
Alcohol consumers were defined as those who consumed alcoholic beverages at least once per 
week over a period of one year or longer; with former alcohol consumers being separated from 
lifelong abstainers. Smokers were defined as those who have ever smoke done or more 
cigarettes per day for at least one year or longer, with past smokers being differentiated from 
life-long non-smokers. Past and current smokers were asked to report their average number of 
cigarettes smoked per day or per week and total months or years of smoking. For never 
smokers, passive smoking information was sought whether they were often exposed to smokers 
at work, public places or at home, and if exposed, the frequency of exposure was inquired. 
Information about sleeping duration per day was also collected. Because most Vietnamese 
habitually take a nap after lunch, this was also recorded and daily sleeping hours was 
calculating by averaging weekdays and weekends. 
 
Dietary assessment 
Dietary habits over the three preceding years were ascertained using a 128-item semi-
quantitative FFQ (Tran, Van Hoang, et al. 2013). This FFQ records the intake of commonly 
consumed food items in Vietnam, which are classified into 15 major food groups (soybean 
products, tomato products, vegetables, fresh fruits, cereal, meat, seafood, egg, cooking oil, 
seasoning, milk, alcohol, tea, coffee, and juice). The frequency of food consumption was 




ascertained according to month, week, or day. A portion size (small, standard, or large) was 
estimated using the picture book developed in a previous study (Kusama et al. 2005). Dietary 
intake of 128 food and beverage items, energy intake, and selected nutrients were computed 
using an ad hoc computer algorithm developed for the FFQ, analysis with reference to the 
standard table of food compositions in Vietnam (National Institute of Nutrition 2007). 
 
Abstraction of clinical data 
Clinical data including fasting plasma glucose and 2-h OGTT, lipid profile (triglycerides, 
LDLC, HDLC, and total cholesterol) were retrieved from medical records. Comorbidities were 
inquired by interviewers and verified by searching medical records or medical log books. The 
first degree-relative family history of diabetes was determined via interviews, to clarify 
whether subjects’ parents, sisters/brothers and their offspring have diabetes. The type of 
diabetes (type 1 or type 2 diabetes) was recorded if applicable. 
 
Measurements and data collection 
A single interviewer was trained by the candidate in interview technique and research 
procedure. The interviewer was a research assistant who had a bachelor degree in public health. 
On a typical day, the interviewer was present at the study site when patient registration began 
in the early morning. Patients who had agreed to participate in the study, would be referred by 
physicians to the interviewer. After explaining the study's purpose, the interviewer asked the 
patient to sign an informed consent form, see Appendix A. One-to-one interviews and 
measurements were scheduled and arranged to obtain information. Cases were selected first, 
and the investigator continuously updated the distribution of sex and age of accumulating cases. 
Selection of controls was made by frequency-matched to cases on a 1:1 ratio for sex and age 
(± 3 years). Participants were requested to respond to a brief questionnaire comprising socio-




demographic, lifestyle questions, and an FFQ. Clinical and laboratory data as well as medical 
history were obtained from both medical records and the personal interview. Anthropometric 
measurements (weight, height, waist and hip circumference) were taken by the investigator.  
 
Body weight was measured with subjects wearing light clothing and no shoes on a digital 
electronic weighing scale (Tanita BC-601, range 0.1 to 150 kg) and recorded to the nearest 100 
g. Standing height was measured using a stadiometer bar, without shoes, with shoulders in a 
relaxed position and arms hanging freely, and recorded to the nearest 0.1 cm. BMI was 
calculated as weight in kilograms divided by height in metres squared. Waist circumference 
(WC) was measured as the minimal abdominal circumference between the lower edge of the 
subcostal ridge and the iliac crests using the plastic measure tape. Hip circumference was 
determined as the broadest buttock circumference. The waist-hip ratio was calculated as WC 
(cm) divided by the hip circumference (cm). Body fat percentage and central adiposity level 
were determined by BIA (BC-601; Tanita Corporation, Tokyo, Japan). Both systolic and 
diastolic blood pressure were measured twice in a sitting position after participant’s rest for at 
least 5 minutes. All equipment had been calibrated. 
 
The transcribed forms were checked by the investigator for completion. Missing, inconsistent, 
or illogical information were clarified with notes and subsequently rectified. Only the principal 
investigator was allowed to correct the information in the forms. An audit trail of data was kept 
of all data collection and data rectification.  
 
Data management 
Hard copy forms of the collected data were temporarily stored in an office accessible to the 
investigator only. Data were entered into Epi-data (Lauritsen JM and Bruus M. 2004), in which 




logical errors, missing information, or incorrect coding could be automatically checked. 
Although basic data cleaning was largely handled by the Epi-data, data entry errors remained 
to be verified. Therefore, range checking, detection and handling of missing data and outliers 
were performed on a daily basis to maximize the completeness of data (WHO 2008b). Outliers 
were examined using Tukey's method (boxplot), diagnostic graphs, standard deviation (SD) 
method (values exceeding mean ± 2 SD), and residual statistics (Studentised residuals, Cook's 
D and leverage measures) (Osborne 2010). Once data entry had been completed, the resulting 
electronic dataset was securely stored in a password-protected computer at the National 
Institute of Hygiene and Epidemiology, Vietnam. 
 
3.2.5 Statistical analysis 
Data from Epi-data were exported to Stata for further cleaning and analyses. Frequency 
distributions were created, and graphs were depicted, to check for outliers and missing values. 
In all analyses, potential confounding variables and effect modifiers were considered. 
Descriptive statistical analyses were initially performed, followed by multivariate regression 
analysis. Specifically, characteristics of variables of interest between cases and controls were 
compared using two-sample t-test and Wilcoxon rank-sum test for normally and non-normally 
distributed continuous variables, respectively, and the Chi-square test for categorical variables. 
Variables related to physical activity, alcohol drinking, smoking, and sleeping duration where 
analysed by employing appropriate statistical methods to ascertain their association with 
T2DM. The association between each exposure of interest and risk of T2DM was investigated 
using unconditional logistic regression models. An OR and 95% CI for T2DM risk according 
to the exposure was presented. Potential confounding factors where considered based on prior 
knowledge, literature review, causal diagram, and change-in-estimate strategies (Greenland 
and Pearce 2015, Greenland 1989). Age and sex were also adjusted for in the multivariable 




models. Interaction of potential effect modifiers on the association between an exposure of 
interest and T2DM was examined using the likelihood ratio test. A test for linear trend across 
categories of an exposure of interest in relation to T2DM was ascertained treating the median 
value for each category of exposure under study as a continuous variable. A two-sided P values 
<0.05 was considered statistically significant. All statistical analyses were performed using the 
Stata 12 (StataCorp LP, College Station, TX, USA). 
 
3.2.6 Ethical considerations 
An information sheet was given to each participant with verbal briefing and explanation. All 
participants provided written informed consent before the conduct of interview and having their 
medical records examined. Ethical approval of this protocol was obtained from the Human 
Research Ethics Committee of Curtin University with the approval number of HR105/2013. 
 
  




CHAPTER 4: RESULTS 
 
4.1 Overview 
This chapter presents results of the study. Section 4.1 overviews the chapter structure. In 
section 4.2, demographic characteristics and other variables are compared between case and 
control groups. In section 4.3, univariate analyses of the association between tea consumption 
and T2DM risk are described. The findings of multivariate regression models are then 
presented for habitual tea consumption in this section. Similarly, results of coffee consumption 
and habitual physical activity are presented, respectively in section 4.4 and 4.5.  
 
4.2 Comparison between case and control groups 
4.2.1 Demographic characteristics 
A total of 1280 (630 cases and 650 controls) were approached and invited for participation. 
From the 1200 study subjects recruited (participation rate 94%), a total of 1198 eligible 
participants (599 cases and 599 controls) were available for analysis due to missing data on 
anthropometric measures on two participants. Complete data were available for all participants 
(n= 1198). The general demographic characteristics of cases and controls were compared in 
Table 4. 
 
As expected from the frequency matched case-control study design, there were no significant 
differences between case and control groups on age, whose average age was about 58.4 years 
(SD 6.6). The mean age was 58.1 (SD 6.6) for men and 58.7 (SD 6.5) for women. Among 
participants, there were 46% men. There were significant differences between case and control 
groups in educational levels, family history of diabetes and occupation (physically light job). 
 




Table 4: Demographic characteristics of participants (n=1198) 
Characteristic Cases Controls p-value 
No. of participants 599 599  
Age in years, mean (SD) 58.6 (6.5) 58.3 (6.6) >0.05 
Female, n (%) 324 (54.0) 324 (54.0) >0.05 
Secondary school completion*, n (%) 283(47.2) 169 (28.2) <0.001 
Physically light job**, n (%) 326 (54.4) 375 (62.6) 0.004 
Family history of diabetes, n (%) 158 (26.4) 56 (9.3) <0.001 
Married, n (%) 587 (97.8) 578 (96.3) 0.123 
Retired, n (%) 474 (79.0) 438 (73.0) 0.015 
P-value for differences between cases and controls; t-test for continuous variables and chi-square test for 
categorical variables. 
* Participants who completed secondary school (year 9) according to the Vietnam Education System. 
** Physically light job refers to office clerk, teacher, and house worker.  
 
 
4.2.2 Lifestyle, anthropometric and other characteristics 
There were significant differences between case and control groups in BMI, WHR, 
hypertension, total cholesterol, and total energy intake. However, alcohol consumption and 
smoking status were not statistically significant as compared between case and control groups; 
see Table 5. 
 
4.3 Tea consumption 
Tea consumption accounted for 59% (707/1198) among participants. As can be seen in Table 
6, the average amount of tea consumption per day was about 317 ml for cases and 392 ml for 
controls. Overall, the control group consumed more tea than the case group. There was a 
statistically significant difference regarding total amount of tea consumption per day between 
case and control groups.   




Table 5: Comparison of variables between case and control groups 
Characteristics Cases Controls p-value 
No. of participants 599 599  
Alcohol consumption, n (%) 275 (45.9) 253 (42.2) 0.20 
Smoking status, n (%)   0.051 
Never  408 (68.1) 444 (74.1)  
Former 100 (16.7) 88 (14.7)  
Current 91 (15.2) 67 (11.2)  
BMI, kg/m2, mean (SD)  23.5 (3.2) 22.7 (2.9) <0.001 
High waist-hip ratio, n (%) 424 (70.7) 383 (63.9) 0.012 
Hypertension, n (%) 121 (20.2) 90 (15.0) 0.019 
Total cholesterol, mmol/l, mean (SD) 5.5 (1.2) 5.2 (1.6) 0.002 
Total energy intake, kcal, mean (SD)  1532 (565) 1330 (474) <0.001 
HDL cholesterol, mmol/l, mean (SD) 1.3 (0.4) 1.1 (0.4) <0.001 
Triglyceride, mmol/l, mean (SD) 2.2 (1.8) 2.5 (2.2) 0.001 
P-value for differences between cases and controls; t-test for continuous variables and chi-square test for 
categorical variables. 
 
Control participants consumed more fresh green tea leaves than their case counterparts, but 
case participants consumed more dried green tea than controls; see Table 6. However, few 
participants habitually drank black tea and/or oolong tea.   
 
Table 6 showed that the proportion of controls who daily consume tea was higher than that of 
cases for both 2-4 cups per day and for more than 4 cups per day (range 1-6 cups). However, 
tea consumption at the lower of fewer than 2 cups per day was similar between cases and 
controls. Among participants who did not drink tea (non-drinkers), the percentage of T2DM 
patients was higher than that of control patients. Cumulative exposure including years (range 
1-50) and cup-years of tea consumption (range 1-90) of the control group was also significantly 
higher than that of the case group. 




Table 6: Comparison of habitual tea consumption between case and control groups  





Amount of tea consumption, ml/day, mean (SD) 317 (233) 392 (355) 0.001 
Type of tea, n (%)    
Dried green tea  270 (55.6) 216 (44.4) 0.001 
Fresh green tea leaves 171 (39.6) 261 (60.4) <0.001 
Black tea 2 (25) 6 (75)  
Oolong tea 1 (10) 9 (90)  
Type of tea, ml/day, mean (SD)    
Dried green tea  217 (173) 181 (195) 0.03 
Fresh leave green tea 274 (211) 401 (242) <0.001 
Black tea - -  
Oolong tea - -  
Number of cups per day, n (%)   0.065 
<2 153 (25.5) 152 (25.3)  
2-4 91 (15.1) 107 (17.8)  
>4 90 (15.0) 114 (19.0)  
Duration of tea drinking (years) 13.6 ( 29.8) 15.5 (11.7) <0.05 
Cumulative tea consumption (cup-years) 28.8 (29.8) 41.3 (55.6) < 0.01 
*P-value for differences between cases and controls; t-test for continuous variables and chi-square test for 
categorical variables. 
 
In Table 7, univariate logistic regression analysis showed that participants who habitually 
consumed tea had lower odds of T2DM (OR 0.76, 95%CI 0.60 to 0.96) than non-drinkers. 
Compared with the non-drinkers, high level of tea consumption (>4 cups per day) was 
associated with lower odds of T2DM (OR 0.67, 95% CI 0.48 to 0.93). Furthermore, high cup-
years (>40) and long exposure (>10 years) to tea drinking were associated with lower odds of 
T2DM in the present study. Overall, a consistent trend in tea consumption being associated 
with lower odds of T2DM was found, with P value for trend<0.01. 





Multivariate logistic regression analyses found an inverse association between habitual tea 
consumption and T2DM risk, as shown in Table 8. After adjusting for confounders, the 
association becomes weaker with OR 0.75 (95%CI 0.57 to 1.00), not statistically significant 
(P=0.051). However, the higher level of tea consumption >4 cups per day, was significantly 
associated with reduced odds of T2DM compared to non-drinkers (OR 0.59, 95%CI 0.40 to 
0.87, P trend= 0.005). Cup-years (>40) and years of tea consumption (>10) also exhibited an 
inverse association with T2DM risk when compared to the reference non-drinkers; adjusted 
ORs were 0.65 (95%CI 0.47 to 0.91, P trend = 0.013) and 0.66 (95%CI 0.47 to 0.92, P trend 
=0.015), respectively.  
 
Table 7: Univariate analysis of tea consumption and T2DM risk 
 Cases/controls Crude OR (95%CI) 
Tea drinking   
No 265/226 Reference 
Yes 335/373 0.76 (0.60 to 0.96) 
Cups per day (1cup=100ml)   
Never or seldom 265/226 Reference 
1-2 95/87 0.93 (0.66 to 1.30) 
>2-4 149/172 0.73 (0.55 to 0.97) 
>4 90/114 0.67 (0.48 to 0.93) 
P for trend†  0.006 
Cup-years   
Non-drinkers 265/226 Reference 
≤40 185/186 0.84 (0.64 to 1.11) 
>40 149/187 0.67 (0.51 to 0.89) 
P for trend†  0.007 
Duration of tea consumption (years)   
Non-drinkers 265/226 Reference 
≤10 173/183 0.80 (0.61 to 1.05) 
>10 161/190 0.72 (0.54 to 0.95) 
P for trend†  0.018 
†Based on unconditional logistic regression models 
 




Table 8: Multivariate analysis of tea consumption and T2DM risk 
 Cases/controls Adjusted ORa (95%CI) 
Tea drinking   
No 265/226 Reference 
Yes 335/373 0.75 (0.57 to 1.00) 
Cups per day (1cup=100ml)   
Never or seldom 265/226 Reference 
1-2 95/87 1.00 (0.67 to 1.48) 
>2-4 149/172 0.76 (0.55 to 1.05) 
>4 90/114 0.59 (0.40 to 0.87) 
P for trend†  0.005 
Cup-years   
Non-drinkers 265/226 Reference 
≤40 185/186 0.86 (0.63 to 1.19) 
>40 149/187 0.65 (0.47 to 0.91) 
P for trend†  0.013 
Duration of consumption (years)   
Non-drinkers 265/226 Reference 
≤10 173/183 0.85 (0.62 to 1.17) 
>10 161/190 0.66 (0.47 to 0.92) 
P for trend†  0.015 
aAdjusted for age (years), sex (female, male), education level (≤secondary school, >secondary school), family 
history of diabetes in first-degree relatives (yes, no), habitual physical activity (irregularly, regularly), alcohol 
consumption (yes, no), smoking status (never, former, current), BMI (kg/m2), Waist-hip ratio (high WHR: males≥ 
0.9, females≥0.85, low WHR: males<0.9, females<0.85) hypertension (yes, no), total cholesterol (mmol/l), coffee 
consumption (yes, no), total energy intake (kcal per day) 









Table 9: Subgroup analysis by gender for tea consumption and T2DM risk 
 Men Women 
 Cases/controls ORb (95%CI) Cases/controls ORb (95%CI) 
Tea drinking     
No 90/61 Reference 175/165 Reference 
Yes 185/214 0.48 (0.31 to 0.76) 149/159 0.94 (0.66 to 1.35) 
Cups per day (1cup=100ml)     
Never or seldom 90/61 Reference 175/165 Reference 
1-2 65/50 0.84 (0.47 to 1.48) 30/37 0.88 (0.48 to 1.63) 
>2-4 63/113 0.31 (0.18 to 0.53) 86/59 1.57 (0.99 to 2.46) 
>4 57/51 0.57 (0.31 to 1.05) 33/63 0.45 (0.26 to 0.78) 
P for trend†  0.001  0.240 
Cup-years     
Non-drinkers 90/61 Reference 175/165 Reference 
≤40 94/110 0.51 (0.30 to 0.84) 91/76 1.23 (0.80 to 1.91) 
>40 91/104 0.48 (0.28 to 0.80) 58/83 0.70 (0.44 to 1.11) 
P for trend†  0.007  0.247 
Duration of consumption (year)     
Non-drinkers 90/61 Reference 175/165 Reference 
≤10 75/93 0.46 (0.27 to 0.79) 98/90 1.19 (0.79 to 1.80) 
>10 110/121 0.51 (0.31 to 0.84) 51/69 0.66 (0.40 to 1.08) 
P for trend†  0.015  0.232 
b Adjusted for age (years), education level (≤secondary school, >secondary school), family history of diabetes in 
first-degree relatives (yes, no), habitual physical activity (irregularly, regularly), alcohol consumption (yes, no), 
smoking status (never, former, current), BMI (kg/m2), Waist-hip ratio (high WHR: males≥ 0.9, females≥0.85, low 
WHR: males<0.9, females<0.85) hypertension (yes, no), total cholesterol (mmol/l), coffee consumption (yes, no), 
total energy intake (kcal per day). 
†Based on unconditional logistic regression models 
 
We conducted a subgroup analysis by sex (Table 9), which showed a statistically significant 
reduction in T2DM risk for men (adjusted OR 0.48, 95%CI 0.31 to 0.76, P trend = 0.002). 




However, the result for women was not significant (adjusted OR 0.94, 95%CI 0.66 to 1.35, P 
trend = 0.80). For the full model, the consumption level of 2-4 cups per day was significantly 
associated with reduced odds of T2DM compared with non-drinkers (OR 0.31, 95%CI 0.18 to 
0.53, P trend= 0.005) for men. For women, the high level of tea consumption (>4 cups per day) 
was associated with lower odds of T2DM, yet not significant (OR 0.45, 95%CI 0.26 to 0.78, P 
trend= 0.24). Similarly, men who maintained tea consumption habits for >40 cup-years and 
>10 years, the reduced odds of T2DM was observed; OR=0.48 (95%CI 0.28 to 0.80) and 
OR=0.51 (95%CI 0.31 to 0.84), respectively. At this same level of exposures as men, women 
had lower odds of T2DM, but their reductions in risk were not statistically significant. The 
interaction term between tea consumption and sex was further analysed in the full model to 
investigate effect modification; however, the interaction term was not significant (P 
value=0.16).   
 
4.4 Coffee consumption 
Among control participants, 28% of them consumed coffee daily and their mean consumption 
was about 66 ml per day, which was higher than the case group; see Table 10. Brewed coffee, 
including black coffee and milk coffee (defined as black coffee mixed with milk, contributed 
79.2% of total coffee consumption, followed by instant coffee with added sugar (20.8%). Data 
in Table 10 also showed that the number of cups of coffee drinking among controls was higher 
than that among cases. The percentage of control participants who drank 1-3 cups of coffee per 
day was higher than that of case participants; 60.0% versus 40.0%. Similarly, for those who 
drank less than 1 cup of coffee per day, the percentage of control participants was also higher 
than their case counterparts; 55.6 versus 44.4%. In addition, years of coffee consumption was 
significant different between case and control groups; the average of more than 12 years for 




controls while only 10.4 years for cases. In contrast, no difference in terms of cup-years was 
found between case and controls group, with P>0.05.  
 
Table 10: Comparison of coffee consumption between case and control groups over the 3 years prior to 
interview 
 Cases (n=145) 
Controls 
(n=192) p-value 
Coffee consumption, ml/day, mean (SD) 63.6 (83.3) 67.5 (77.5) 0.65 
Type of coffee, n (%)    
Black coffee  81 (54.7) 67 (45.3) 0.21 
Instant coffee 24 (31.6) 52 (68.4) 0.001 
Milk coffee 54 (38.0) 88 (62.0) 0.002 
Type of coffee, ml/day, mean (SD)    
Black coffee  75.9 (95.5) 79.5 (64.8) 0.79 
Instant coffee 55.4 (58.7) 62.5 (96.0) 0.73 
Milk coffee 32.3 (43.4) 49.0 (60.4) 0.06 
Number of cups per day, n (%)    
<1  103 (44.4) 129 (55.6) 
0.008 
1-3 42 (40.0) 63 (60.0) 
Years of consumption, mean (SD) 10.4 (4.2) 12.2 (8.5) 0.018 
Cup-years, mean (SD) 6.5 ± 8.6 8.8 ± 13.4 0.07 
P-value for differences between cases and controls; T-test for continuous variables and Chi-square test for 
categorical variables. 
 
In univariate analysis, coffee consumption was associated with reduced odds of T2DM, see 
Table 11. Our results found that an additional cup of coffee per day conferred a 25% risk 
reduction (crude OR 0.75, 95%CI 0.63 to 0.90) while drinking 1-3 cups per day had a 41% 
reduced odds (crude OR 0.59, 95%CI 0.39 to 0.90). The higher exposure in terms of cup-years 
(>20) and duration (>10 years) also showed significantly T2DM risk reduction, without 
accounting for the effect of confounding variables.  




Table 11: Univariate analysis of coffee consumption and T2DM risk 
 
Cases/controls Crude OR (95%CI) 
Coffee drinking   
No 454/407 Reference 
Yes 145/192 0.67 (0.52 to 0.87) 
Frequency of coffee consumption (cup/day)   
Never or seldom 454/407 Reference 
<1  103/129 0.71 (0.53 to 0.95) 
 1-3  42/63 0.59 (0.39 to 0.90) 
P for trend†  0.002 
Cup-years   
Non-drinkers  454/407 Reference 
<20  68/93 0.65 (0.46 to 0.92) 
≥20  77/99 0.69 (0.50 to 0.96) 
P for trend†  0.007 
Years of consumption   
Non-drinkers 454/407 Reference 
≤10 106/121 0.78 (0.58 to 1.05) 
>10 39/71 0.49 (0.32 to 0.74) 
P for trend†  <0.001 
 
†Based on unconditional logistic regression models 
 
 
In the multivariate models, coffee consumption was associated with reduced odds of T2DM. 
Each additional cup of coffee per day may offer a 27% risk reduction (OR 0.73, 95%CI 0.59 
to 0.90) and coffee drinkers of 1-3 cups per day had a 45% reduced odds (OR 0.55, 95%CI 0.34 
to 0.88). Cup-years (≥20) and duration (>10 years) also demonstrated an inverse association 
with T2DM risk when compared to the reference non-drinkers; adjusted ORs were 0.67 




(95%CI 0.46 to 0.98, P trend= 0.013) and 0.41 (95%CI 0.25 to 0.67, P trend= 0.001), 
respectively. 
 
Table 12: Multivariate analysis of coffee consumption and T2DM risk 
 
Cases/controls Adjusted ORa (95%CI) 
Coffee drinking   
No 454/407 Reference 
Yes 145/192 0.66 (0.49 to 0.88) 
Frequency of coffee consumption (cup/day)   
Never or seldom 454/407 Reference 
<1  103/129 0.71 (0.51 to 1.00) 
 1-3  42/63 0.55 (0.34 to 0.88) 
P for trend†  0.004 
Cup-years   
Non-drinkers 454/407 Reference 
<20  68/93 0.64 (0.43 to 0.96) 
≥20  77/99 0.67 (0.46 to 0.98) 
P for trend†  0.013 
Duration of consumption (years)   
Non-drinkers  454/407 Reference 
≤10 106/121 0.81 (0.58 to 1.13) 
>10 39/71 0.41 (0.25 to 0.67) 
P for trend†  0.001 
 
a Adjusted for age (years), sex (female, male), education level (≤secondary school, >secondary school), 
occupation (physically heavy job, physically light job), family history of diabetes in first-degree relatives (yes, 
no), habitual physical activity (irregularly, regularly), alcohol consumption (yes, no), smoking status (never, 
former, current), BMI (kg/m2), waist-hip ratio (high WHR: males≥ 0.9, females≥0.85, low WHR: males<0.9, 
females<0.85 ) hypertension (yes, no), total cholesterol (mmol/l), tea consumption (yes, no), total energy intake 
(kcal). 
SD: standard deviation. 
†Based on unconditional logistic regression models 
 
Table 13 shows that the risk of T2DM associated with total coffee consumption. The interaction 
term between total coffee consumption and sex was significant in the full model (P=0.04). 
Women drinking 1-3 cups of coffee daily had a significantly lower risk (OR 0.25, 95%CI 0.11 




to 0.55, P trend<0.001) than others reporting non-drinking whereas the relationship in men was 
not significant (OR 0.94, 95%CI 0.50 to 1.79, P trend=0.525). 
 
Table 13: Subgroup analysis by gender for coffee consumption and T2DM risk 
 
Men Women 
Cases/controls ORb (95%CI) Cases/controls ORb  (95%CI) 
Coffee drinking     
No 189/179 Reference 265/228 Reference 
Yes 86/96 0.81 (0.53 to 1.23) 59/96 0.49 (0.32 to 0.77) 
Frequency of coffee 
consumption (cup/day)     
Non-drinkers 189/179 Reference 265/228 Reference 
<1  57/66 0.75 (0.46 to 1.22) 46/63 0.64 (0.39 to 1.05) 
 1-3  29/30 0.94 (0.50 to 1.79) 13/33 0.25 (0.11 to 0.55) 
P for trend†  0.525  <0.001 
Cup-years     
Non-drinkers 189/179 Reference 265/228 Reference 
<20  35/50 0.56 (0.31 to 1.00) 33/43 0.69 (0.39 to 1.21) 
≥20  51/46 1.08 (0.64 to 1.82) 26/53 0.36 (0.20 to 0.64) 
P for trend†  0.816  <0.001 
Years of consumption     
Non-drinkers 189/179 Reference 265/228 Reference 
≤10 63/66 0.89 (0.55 to 1.42) 43/55 0.70 (0.42 to 1.15) 
>10 23/30 0.64 (0.32 to 1.27) 16/41 0.23 (0.11 to 0.49) 
P for trend†  0.222  <0.001 
b Adjusted for age (years), education level (≤secondary school, >secondary school), occupation (physically heavy 
job, physically light job), family history of diabetes in first-degree relatives (yes, no), habitual physical activity 
(irregularly, regularly), alcohol consumption (yes, no), smoking status (never, former, current), BMI (kg/m2), 
waist-hip ratio (high WHR: males≥ 0.9, females≥0.85, low WHR: males<0.9, females<0.85 ) hypertension (yes, 
no), total cholesterol (mmol/l), tea consumption (yes, no), total energy intake (kcal). 
†Based on unconditional logistic regression models 




4.5 Physical activity 
Table 14 shows that only 9.7% of cases (n=58) reported their participation in strenuous physical 
activity as a habit, compared to 7.7% (n=46) for non-T2DM patients. There was no significant 
difference (P>0.05) between case and control groups for the strenuous sports in our study but 
when combining strenuous and vigorous activities the case group had significantly higher 
(P=0.03) participant rate (12.5%) than the control group (8.3%). Similarly, participants who 
had a habit of doing vigorous activity were fewer; 3.0% (n=17) of cases and 0.7% (n=4) of 
controls. However, the study participants tended to engage more time in moderate activity than 
strenuous sports and vigorous activity. The average hours per week spent on moderate activity 
were 3.6 (SD=3.0) for cases and 4.6 (SD=3.4) for controls, their difference being statistically 
significant with P<0.01. Overall, total physical activity was 17.0 MET-hours per week for cases 
versus 21.4 MET-hours per week for controls (P<0.001).  
 
Table 14: Comparison of physical activity and sitting duration between case and control groups 
Activity Cases n=599 
Controls 
n=599 p-value 
Habitual physical activity    
Strenuous sports, n (%) 58 (9.7) 46 (7.7) 0.21 
Vigorous activity, n (%) 17 (2.8) 4 (0.7) - 
Moderate activity, hours/week, mean (SD) 3.6 (3.0) 4.6 (3.4) <0.001 
Total physical activity, MET-hours/week, mean (SD) 17.0 (13.9) 21.4 (15.2) <0.001 
Lifelong physical activity   <0.001 
Never been much involved, n (%) 276 (46.1) 189 (31.5)  
Intermittently active, n (%)  87 (14.5) 93 (15.5)  
Always been involved, n (%) 236 (39.4) 317 (53.0)  
Total sitting duration, hours/week, mean (SD) 38.5 (21.7) 30.2 (17.6) <0.001 
T-test for comparing two means, Chi-squared test for comparing category variables. 
 




Concerning lifelong physical activity, the present study showed that the control group had a 
higher prevalence than the case group for actively involving and doing physical activity (53.0% 
versus 39.4%). In addition, total average sitting hours per week was also significantly higher 
in the case group when compared to their control counterparts (38.5 versus 30.2), P<0.001.  
Table 15: Univariate analysis of physical activity and T2DM risk 
 Cases, n (%) Controls, n (%) Crude OR (95% CI) 
Habitual physical activity    
Moderate activity (hours/week)    
<3 254 (42.4) 216 (36.1) Reference 
3-5 169 (28.2) 176 (29.4) 0.81 (0.61 to 1.07) 
>5 176 (29.4) 207 (34.5) 0.72 (0.55 to 0.94) 
Total activity (MET-
hours/week)*    
<13 229 (38.2) 188 (31.4) Reference 
13-26 202 (33.7) 216 (36.0) 0.76 (0.58 to 1.00) 
>26 168 (28.1) 195 (32.6) 0.70 (0.53 to 0.93) 
Lifelong physical activity    
Never been much involved 276 (46.1) 189 (31.5) Reference 
Intermittently active  87 (14.5) 93 (15.5) 0.64 (0.45 to 0.90) 
Always been involved 236 (39.4) 317 (53.0) 0.50 (0.39 to 0.65) 
Total sitting duration (hours/week)    
<20 117 (19.5) 170 (28.4) Reference 
20-35 207 (34.5) 239 (39.9) 1.25 (0.93 to 1.69) 
>35 275 (46.0) 190 (31.7) 2.10 (1.55 to 2.83) 
* Included strenuous and vigorous activities   
 
Univariate analysis showed that the controls engaged in longer duration and participated in 
more moderate activity than the cases (P <0.05). The average weekly time spent at least 5 hours 
on moderate activities was 29.4% for cases and 34.5% for controls, see Table 15.  Because the 




great majority of subjects did not participate in any strenuous and vigorous activities, the effect 
of these activities on T2DM risk cannot be separately analysed in the present study.  
 
Table 16: Multivariate analysis of physical activity and T2DM risk 










Habitual physical activity      
Moderate activity  
(hours/week)     <0.001 
<3 254 (42.4) 216 (36.1) Reference Reference  
3-5 169 (28.2) 176 (29.4) 0.77 (0.58 to 1.02) 0.79 (0.58 to 1.08)  
>5 176 (29.4) 207 (34.5) 0.71 (0.54 to 0.94) 0.68 (0.51 to 0.93)  
Total activity  
(MET-hours/week)*     <0.001 
<13 229 (38.2) 188 (31.4) Reference Reference  
13-26 202 (33.7) 216 (36.0) 0.72 (0.55 to 0.95) 0.75 (0.55 to 1.01)  
>26 168 (28.1) 195 (32.6) 0.69 (0.52 to 0.92) 0.66 (0.48 to 0.91)  
Lifelong physical activity     <0.001 
Never been much 
involved 276 (46.1) 189 (31.5) Reference Reference  
Intermittently active  87 (14.5) 93 (15.5) 0.59 (0.42 to 0.85) 0.54 (0.36 to 0.80)  
Always been involved 236 (39.4) 317 (53.0) 0.48 (0.37 to 0.62) 0.46 (0.35 to 0.62)  
Total sitting duration 
(hours/week)      
<20 117 (19.5) 170 (28.4) Reference Reference <0.001 
20-35 207 (34.5) 239 (39.9) 1.24 (0.92 to 1.68) 1.24 (0.89 to 1.73)  
>35 275 (46.0) 190 (31.7) 2.15 (1.57 to 2.95) 2.32 (1.64 to 3.29)  
a Adjusted for age (years), sex (female, male), BMI (kg/m2). 
b Adjusted for age (years), sex (female, male), education level (≤secondary school, >secondary school), 
occupation (physically heavy job, physically light job), family history of diabetes in first-degree relatives (yes, 
no), alcohol consumption (yes, no), smoking status (never, former, current), hypertension (yes, no), total 
cholesterol (mmol/l), BMI (kg/m2), total energy intake (kcal).  
c Separated unconditional logistic models. * Included strenuous and vigorous activities  
 
In terms of total physical activity, an inverse association with T2DM risk was found for the 
high level of >26 MET-hours per week compared to <13 MET-hours per week (OR0.70, 95% 




CI 0.53 to 0.93), see Table 15. In addition, a two-fold increase in risk of T2DM was seen for 
participants who spent more than 35 hours sitting per week compared to <20 hours sitting per 
week.    
 
Table 16 presented the multivariate logistic regression results. The reasons of presenting two 
adjusted OR models were to assess the additional effects of other confounding variables apart 
from age, gender and BMI. Significant inverse association with T2DM risk was evident for 
moderate activity. For total physical activity exposure, the T2DM risk decreased by 34% for 
engaging in 26 or more MET-hours per week relative to less than 13 MET-hours per week. 
The corresponding dose–response relationship was also significant with P for trend <0.001. In 
terms of lifelong physical activity, there was a consistent reduced odds of T2DM for 
participants who actively involved in physical activity compared with those less involved. The 
multivariate results also ascertained that the increase in T2DM risk for a longer sitting duration 
of 35 or more hours per week relative to less than 20 hours per week. No interaction between 
sex and moderate physical activity (P=0.3), total MET (P =0.2), and sitting duration (P =0.85) 
was found. 
 
Table 17 showed that subgroup analysis by gender investigating the association between 
physical activity and T2DM risk. Although men tended to have more benefit by doing physical 
activities than women, no significant differences between men and women in all categories of 
physical activities with respect to T2DM risk was evident. However, we found the significant 
dose-response relationship between total physical activity and T2DM risk for both men and 
women with P<0.01. For each additional MET-hour per week of total physical activity 
exposure, a consistent risk reduction of T2DM in both men (0.97, 95%CI 0.96 to 0.98) and 
women (0.98, 95% CI 0.97 to 0.99) was showed in the present study.   




Table 17: Adjusted ORs of T2DM for habitual physical activity in men and women 









Habitual physical activity     
Moderate activity 
(hours/week)     
<3 116/99 Reference 138/117 Reference 
3-5 78/80 0.82 (0.51 to 1.32) 91/96 0.76 (0.50 to 1.16) 
>5 81/96 0.68 (0.43 to 1.08) 95/111 0.71 (0.47 to 1.07) 
P for trend  <0.001  <0.001 
Total activity (MET-hours/week)*     
<13 102/85 Reference 127/103 Reference 
13-26 95/100 0.75 (0.47 to 1.19) 107/116 0.75 (0.50 to 1.14) 
>26 78/90 0.67 (0.41 to 1.08) 90/105 0.69 (0.45 to 1.06) 
P for trend  <0.001  <0.001 
1 SD increment  0.97 (0.96 to 0.98)  0.98 (0.97 to 0.99) 
Lifelong physical activity     
Never been much involved 130/71 Reference 146/118 Reference 
Intermittently active  35/34 0.38 (0.20 to 0.74) 52/59 0.64 (0.39 to 1.06) 
Always been involved 110/170 0.31 (0.20 to 0.48) 123/147 0.65 (0.45 to 0.96) 
P for trend  <0.001  <0.001 
Total sitting duration 
(hours/week)     
<20 49/69 Reference 68/101 Reference 
20-35 87/112 1.11 (0.65 to 1.88) 120/127 1.39 (0.90 to 2.16) 
>35 139/94 2.22 (1.29 to 3.83) 96/136 2.50 (1.57 to 3.97) 
P for trend  <0.001  <0.001 
cAdjusted for age (years), education level (≤secondary school, >secondary school), occupation (physically heavy 
job, physically light job), family history of diabetes in first-degree relatives (yes, no), alcohol consumption (yes, 
no), smoking status (never, former, current), hypertension (yes, no), total cholesterol (mmol/l), BMI (kg/m2), total 
energy intake (kcal).  
* Included strenuous and vigorous activities  
SD: standard deviation  
 




The present study found that BMI was a significant predictor of T2DM. Total physical activity 
was inversely associated with T2DM risk for participants who had BMI<25 kg/m2. However, 








CHAPTER 5: DISCUSSION 
 
 
In this chapter, the results presented in the chapter 4 are discussed in relation to the main aims 
of the study, which were to investigate the association between the tea, coffee consumption, 
physical activity and T2DM risk in Hanoi city, Vietnam. In relation to each specific objective, 
comparisons between the main findings in the present study and those in the literature are also 
reported, together with description of the plausible underlying mechanisms. Strength and 
limitations of the study will then be discussed.  
 
5.1 Tea consumption and T2DM risk 
Our study found that about 73% men and 48% women in Hanoi city, Vietnam, drink tea. The 
majority of participants reported green tea consumption. In the present study, higher tea 
consumption was associated with significantly reduced odds of T2DM (OR=0.59, 95%CI, 0.40 
to 0.87). The association with the decreased T2DM risk appeared to be similar for both men 
and women, but more consistent among men. To our knowledge, this is first observational 
study in Vietnam investigating the association between habitual tea consumption and T2DM 
risk.  
 
The inverse association between tea consumption and T2DM has also been observed in cohort 
studies. Namely, a study in US (n=7006; 8.4 years of follow-up) showed that about 23% 
reduced risk of T2DM for persons aged 60 years or less who had regular tea drinking; HR 0.77, 
95% CI 0.59 to 1.00; P <0.05 (Greenberg et al. 2005b). A similar reduction in T2DM risk was 
found in the present study after adjustment of confounders; OR 0.75, 95% CI 0.57 to 1.00. 
Despite of consistent findings were showed in both studies the study designs are different 




(prospective cohort study design versus case-control study design). In terms of cups of tea per 
day, our findings suggested that drinking tea regularly 2-4 cups per day (100ml per cup) was 
inversely associated with T2DM risk (reduction of 24%). At high level of consumption (>2 
cups per day), T2DM risk was reduced by over 60% (HR 0.37, 95% CI 0.16 to 0.85, P<0.05) 
for the US study. Besides, regular tea consumption in the US study was unclear whether black 
tea, green tea or oolong tea was consumed, and the quantity of containers (cup) was not 
presented. In our study, the majority of participants drank green tea. Due to few case-control 
studies on tea consumption and T2DM risk, comparison of the current study findings with 
previous cohort studies are necessary. In a large study of 17,413 middle aged Japanese men 
and women, Iso et al.(Iso et al. 2006) observed that green tea consumption of 1 - 6 cups per week 
was associated with 34% reduction in T2DM risk after a 5-year follow up and adjusting for 
confounders. The inverse association between tea consumption and T2DM risk was also 
ascertained in a Mediterranean study (n=1040; 2 years of follow-up) (Panagiotakos et al. 2009).  
 
However, the findings on the relationship between tea consumption and T2DM risk were not 
always consistent. A prospective cohort study in Singapore conducted on 36,908 participants 
(5 years of follow-up) suggested that participants reporting ≥1 cup of black tea per day had a 
14% reduction in T2DM risk (RR 0.86, 95% CI 0.74 to 1.00) compared to participants who 
were non-drinkers, but no such inverse association for green tea consumption (Odegaard et al. 
2008). The difference may be explained their qualitative assessment the levels of green tea 
consumption such as never or monthly, weekly or daily, but could not quantity consumption in 
terms of number of cups per time unit.  
 
In addition, our findings cohere with a recent meta-analysis of cohort studies showing that the 
reduced risk of T2DM among individuals with higher tea consumption (≥3 cups per day) 




compared to those who were non-drinkers (Yang, Mao, et al. 2014). A subgroup analysis of 
the meta-analysis also found a significant association between tea consumption and decreased 
T2DM risk in the Asian population (RR 0.84, 95%CI 0.71 to 1.00), but not in the American 
and European populations (RR 1.00, 95%CI 0.97 to 1.04). The different types of tea consumed 
in different regions may offer an explanation. It is well known that black tea is commonly 
consumed in the USA and European countries, whereas green tea is preferred in Asian 
countries (Yang, Mao, et al. 2014). However, no comparison between the types of tea (black 
tea, green tea, oolong tea) and T2DM risk was performed in this meta-analysis. 
 
We examined the association between frequency intensity of cups consumed per day and 
T2DM risk. The lower levels of tea consumption (1-2 or 2-4 cups per days) were not 
significantly associated with the T2DM risk. However, a significant association with the 
decreased risk of T2DM by about 40% was evident at the higher consumption level (>4 cups 
per day); adjusted OR 0.59, 95%CI 0.40 to 0.87. Our findings were slightly different from 
previous meta-analysis studies. For example, Jing et al (Jing et al. 2009) showed that ≥4 cups 
per day of tea consumption was associated with reduced risk of T2DM by 20% (RR 0.80, 
95%CI 0.70 to 0.93) while a meta-analysis conducted by Huxley et al (Huxley et al. 2009) 
showed that daily tea consumption (3–4 cups per day) was associated with a lower T2DM risk 
by approximately 15%. 
 
To verify the effect of cumulative tea consumption on the risk of T2DM, we investigated cup-
years and year of tea consumption. The results suggested that both cup-years (>40) and tea 
consumption duration (>10 years) were significantly associated with reduced odds of T2DM, 
(P<0.05). The odds of T2DM was reduced by 35% for participants who had more than 40 cup-




years of cumulative tea consumption and 34% for those who drank tea for more than 10 years, 
relative to non-drinkers.  
 
Some observational studies have found the inverse association between green tea consumption 
and T2DM risk (Yang, Mao, et al. 2014). However, the effects of green tea consumption on 
blood glucose control and insulin sensitivity are inconsistent in many interventions. Fukino et 
al (Fukino et al. 2005) conducted a randomised controlled trial (66 patients aged 32-73 years; 
53 males and 13 females with borderline diabetes or diabetes) to evaluate the effect of green 
tea polyphenol intake on insulin resistance. The trial revealed that the daily supplementary 
intake of 500 mg of green tea polyphenols did not have clear effects on blood glucose level, 
HbA1c level and insulin resistance. However, recent trials showed that green tea 
supplementation might increase insulin activity (Mirzaei et al. 2015, Hsu et al. 2011, Bogdanski 
et al. 2012, Wu, Juan, Ho, et al. 2004). For example, Wu et al (2004) found that green tea 
polyphenols increased glucose uptake of adipocytes and suggested that polyphenols in green 
tea might be responsible for increasing insulin activity. A recent meta-analysis of 17 
randomised controlled trials conducted from 1980 to 2013 in human found that green tea 
significantly lowered fasting glucose, HbA1c concentrations, and may also reduce fasting 
insulin concentrations (Liu et al. 2013).  
 
Although observational studies have found a beneficial role of tea consumption against T2DM, 
the apparent mechanism by which tea can protect against the development of T2DM remains 
controversial. The first possible mechanism is through ameliorating insulin resistance (Wu, 
Juan, Hwang, et al. 2004). It is well known that insulin resistance is one of the biomarkers of 
T2DM progression. T2DM is defined as a progressive condition in which the body becomes 
resistant to the normal effects of insulin and/or gradually loses the capacity to produce enough 




insulin in the pancreas. Therefore, improving the insulin resistance or increasing insulin 
activity may be useful for T2DM prevention. Moreover, polyphenol is one of the chemical 
components found in green tea. Intakes of green tea and black tea extracts have been found to 
be associated with lower blood glucose in streptozotocin-induced diabetic rats (Gomes et al. 
1995). In addition, Deng et al. (Zeyuan et al. 1998) found that serum glucose and triglyceride 
levels in rats decreased after green tea supplementation. Another study (Wu, Juan, Ho, et al. 
2004) showed that plasma insulin levels in the green tea group were lower than their 
comparison group after 12 weeks of supplementation. In other words, the insulin sensitivity of 
the rats improved as a result of green tea supplementation. Higher glucose uptake activity was 
evident in the green tea group than the control group, indicating that the effect of green tea on 
improving insulin sensitivity. The green tea extracts helped adipocytes to increase their glucose 
uptake, consequently increasing insulin sensitivity. 
 
Another mechanism is the tea polyphenol (–)-epigallocatechin-3-gallate (EGCG), which 
exhibits some antidiabetic effects (Lin and Lin 2008). Potential mechanism concerns high 
glucose induced insulin signalling blockade in HepG2 cells. High glucose condition generates 
intracellular reactive oxygen species (ROS), which are accumulated within the HepG2 cells. 
The high glucose-induced oxidative stress triggers serine kinase cascades by activating protein 
kinase C (PKC) and c-Jun N-terminal kinase (JNK). Accordingly, it induces Ser307 
phosphorylation of critical insulin receptor substrate sites (IRS-1), reducing IRS-1 tyrosine 
phosphorylation, and thereby inhibiting IRS-1 binding to insulin receptor (IR)(Lin and Lin 
2008). These results down regulate phosphatidyl inositol 3 kinase (PI3KAkt) signalling 
pathway and decrease insulin-stimulated glucose uptake and glycogen synthesis. However, 
IRS-1 tyrosine phosphorylation has been demonstrated to be positively regulated by 5’-AMP-
activated protein kinase (AMPK) activation. EGCG was shown to both reduce PKC/JNK 




activation and activate AMPK activity leading to block IRS-1 serine phosphorylation and 
attenuate high glucose-induced insulin signalling blockade (Li et al. 2011).  
 
A study found that black tea extracts possess curative effect on streptozotocin-induced diabetes 
in mice (Manikandan et al. 2009). The findings confirmed that the number of β cells increased 
in the islets of the diabetic mice fed with black-tea extract. Also, an increase in secretory 
granules in the cells indicates that the cells have been stimulated for hormone synthesis. 
However, little information is available in green tea extract. Green tea is more effective as a 
preventive agent via improved insulin sensitivity whereas black tea extract appears to be more 
effective as a curative. In the present study, the inverse association between habitual green tea 
consumption and T2DM risk may be explained by the preventive role of green tea constituents, 
especially polyphenols.   
 
Subgroup analysis on sex showed a difference between men and women in accordance to 
habitual green tea consumption and the risk of T2DM. We found that the inverse association 
between tea consumption and T2DM risk is consistent with a recent meta-analysis (Yang, Mao, 
et al. 2014). Besides, a Japanese study observed an inverse relationship between tea 
consumption and T2DM in women, but not in men (Iso et al. 2006). Although we observed the 
reduced odds of T2DM in both men and women, there is a significant association among 
women at the high level of tea consumption (>4 cups per day), but not significant among men 
at the same consumption level. One possible explanation for the sex difference is the lower 
prevalence of drinking tea among women than men; 48% versus 73%, respectively. In addition, 
the average duration of tea consumption among women (13.1 years, SD=10.9) was also shorter 
than that of men (15.8 years, SD=9.5). Another possible biological explanation for the sex 
difference is that high testosterone level is associated with the higher risk of T2DM in women 




but the lower T2DM risk in men (Grossmann 2011, Ding et al. 2006). In an animal study, tea 
intake increases total testosterone levels in male rats (Satoh et al. 2002). Therefore, tea 
consumption may elevate testosterone level in men and in turn decrease the T2DM risk.  
 
5.2 Coffee consumption and T2DM risk 
 
The current study has found that habitual coffee consumption was associated with lower odds 
of T2DM prevalence. This association was significant for the increasing frequency of drinking 
(number of cups per day) with P trend value <0.01. After adjusting for confounders, 
participants who maintained a habit of coffee consumption 1-3 cups every day had a lower risk 
of T2DM than non-drinkers. Besides, the findings also showed that higher cumulative exposure 
in terms of cup-years (≥20) and years of coffee drinking (>10 years) appeared to be negatively 
associated with the lower odds of T2DM. In sub-analysis by sex, we found significant inverse 
association with T2DM risk among women with higher coffee consumption (1-3 cups per day). 
The highest level of habitual coffee intake was related to a 75% lower T2DM risk in women 
but only a 6% non-significant reduction of risk in men. It should be remarked that the 
substantially higher levels of coffee consumption in other studies than our participants. In 
summary, habitual coffee consumption was found to be linked to a lower risk of T2DM among 
Vietnamese women.  
 
Consistent with previous studies, coffee consumption was associated with a reduced risk of 
T2DM (Van Dam and Hu 2005, Muley, Muley, and Shah 2012, Huxley et al. 2009). Meta-
analyses indicated a weak dose–response relationship between coffee and T2DM, but several 
individual studies reported more of a threshold effect with a substantial risk reduction (20–
45%) already at consumption levels of around three cups per day (Rosengren et al. 2004, 




Tuomilehto et al. 2004, Carlsson et al. 2004, van Dam et al. 2006). Consistent with two meta-
analyses that found inverse association with T2DM risk (Huxley et al. 2009, Van Dam and Hu 
2005), we found a 27% reduced risk in consumers of 1–3 cups per day. The first meta-analysis 
included 9 prospective cohorts with about 190,000 participants in America and Europe and 
reported that habitual coffee consumption of 4–6 and 6–7 cups per day reduced risk by 28% 
and 35%, respectively (Van Dam and Hu 2005). The second meta-analysis recently 
summarized 18 cohort studies including 457,922 subjects with more than 21,000 incident cases 
of T2DM; and concluded that each additional cup of coffee contributed to a 5% to 10% lower 
risk (Huxley et al. 2009). This review also reported a reduced T2DM risk for those who drank 
3–4 cups of decaffeinated coffee per day (HR 0.64, 95% CI 0.54 to 0.77) (Huxley et al. 2009). 
After these meta-analyses had published, four new cohort studies published their findings, 
which are also in agreement (Oba et al. 2010, Boggs et al. 2010, Floegel et al. 2012, Doo et al. 
2014).  
 
Among the four new cohort studies regarding coffee consumption and T2DM risk, the first 
study was the Hawaii component of the Multiethnic Cohort (MEC) (Doo et al. 2014).  It was 
conducted on a multiethnic population. The highest category of regular coffee consumption 
was related to a 34% lower T2DM risk in women but only a borderline 14% reduction of risk 
in men. The benefit of coffee consumption was found in women of all 3 ethnic groups: 
Caucasians, Japanese Americans, and Native Hawaiians. The interaction term with ethnicity 
was not significant despite some variations in effect size. It concluded that regular, but not 
decaffeinated, coffee intake was more protective against T2DM in women of all ethnic groups 
than in men.  
 




The second was the European Prospective Investigation into Cancer and Nutrition (EPIC)-
Germany study conducted in 10 European countries (Floegel et al. 2012). The study 
investigated the association between coffee consumption and the risk of chronic diseases 
prospectively, including T2DM, myocardial infarction, stroke, and cancer. With more than 
42,000 participants prospectively observed over 8.9 years, 1,432 incident cases of T2DM 
occurred. Coffee consumption was assessed by a self-administered food frequency 
questionnaire. No association between high coffee consumption (≥4 cups per day) with the 
overall risk of chronic diseases was observed when compared to less than one cup per day. 
However, it reported a 23% lower incidence of T2DM for caffeinated intakes of ≥4 cups per 
day (one cup was defined as 150 mL). Similar to the MEC study, the findings of the EPIC 
supported the beneficial role of coffee consumption and T2DM risk at the population level. 
Although the EPIC study did not test for the interaction term between sex and coffee 
consumption, the interaction term between smoking and caffeinated coffee consumption was 
analysed. Among non-smokers, an inverse association was found between caffeinated coffee 
consumption and risk of T2DM; among current smokers, such dose-dependent inverse 
association was not observed. Because smoking is an established risk factor for T2DM, the 
adverse effects of smoking may cancel out the potential benefits of coffee consumption on 
T2DM risk. Thus, the EPIC study concluded that smokers might not benefit from coffee 
consumption with respect to the T2DM risk.  
 
 
Thirdly, the Black Women’s Health study (Boggs et al. 2010) included 46,906 African 
American women aged 30–69 years at baseline in 1995. Dietary intake was assessed in 1995 
and 2001 by using a validated FFQ. During 12 years of follow-up, there were 3,671 incident 
cases of T2DM. The study findings supported that moderate consumption of caffeinated coffee 
(2-3 cups per day) could reduce the risk of T2DM in African American women. Similarly, the 




present study also found the inverse association between coffee consumption and the risk of 
T2DM for Vietnamese women. About 24% of Vietnamese women drinks coffee while a lower 
percentage was observed among African American women (14% for both caffeinated and 
decaffeinated coffee). Decaffeinated coffee drinkers reported healthier lifestyles in terms of 
physical activity, weight, and diet, but adjustment for these factors did not appear to attenuate 
the association between decaffeinated coffee intake and T2DM risk. The lack of significance 
for decaffeinated coffee may be due to confounding. Since caffeine is regarded as an 
“unhealthy” substance by some, individuals diagnosed with hypertension or heart disease 
might have switched to decaffeinated coffee after early signs of illness were noted (Doo et al. 
2014, Shlonsky, Klatsky, and Armstrong 2003). In our study, because of the low prevalence of 
drinking decaffeinated coffee among Vietnamese adults, no such information was collected.   
 
Fourthly, a Japanese cohort study (Oba et al. 2010) reported a lower risk of T2DM for regular 
coffee consumption, but not caffeinated. The association between estimated total caffeine 
intake and risk of T2DM was non-significant both among men and among women. The results 
imply that coffee consumption could reduce the risk of developing T2DM, whose protective 
effect may exist independent of the influence of caffeine intake.  
 
Adjusted and unadjusted models in the present analytical observational study suggested that 
the inverse association for coffee consumption is stronger for women than for men. Two other 
observational studies (Kato et al. 2009, Bidel et al. 2008) showed similar results. A Japanese 
cohort study found an 18% lower risk in men but 60% lower risk in women who drank ≥5 cups 
per day (Kato et al. 2009). A study in Finland reported a 29% lower risk in men and a 53% 
lower risk in women (Bidel et al. 2008). However, two studies observed that T2DM risk among 
men was lower among men than women when drank 4 or more cups of coffee per day (Paynter 




et al. 2006, Salazar-Martinez et al. 2004) while the protective effects were similar across sex 
in two other studies (Oba et al. 2010, Iso et al. 2006). Hormonal mechanisms for a sex-
differential aetiology have been proposed (Tuomilehto et al. 2004), but appear unlikely given 
the relative consistency of effect sizes in meta-analyses (van Dam 2008, Natella and Scaccini 
2012).  
 
Another plausible explanation is reporting of coffee consumption being less accurate by men 
relative to women, which led to reduced risk estimates. The original calibration study provides 
some evidence for lower correlations among Caucasian men than women (Stram et al. 2000). 
Finally, our results could be a chance finding. Only a few of the studies have provided 
information by ethnicity. Four studies in Asia have been conducted (Oba et al. 2010, Kato et 
al. 2009, Iso et al. 2006, Odegaard et al. 2008), but none specifically analysed Vietnamese. 
Two studies on Native Americans (Zhang et al. 2011, Saremi, Tulloch-Reid, and Knowler 
2003), one on African-American women (Boggs et al. 2010), and another study on Puerto 
Ricans (Fuhrman et al. 2008) agreed that coffee is associated with a lower risk of T2DM. 
Results from these 8 studies are consistent with our study findings, in particular in regard to 
the stronger association among women. 
 
Our study results were in agreement with the beneficial role of total coffee consumption for 
T2DM development in women, but not observed in men. Similarly, the prolonged duration of 
coffee consumption (including cup-years and years of consumption) was analysed by sex.  The 
interaction term between sex and total coffee consumption was marginally significant with P 
= 0.046. In Vietnam, more than 60% of male adults currently or used to smoke whereas females 
are almost non-cigarette smokers. Participants who were male smokers accounted for more 




than 61% whereas only 1% of women reported currently smoke cigarettes or used to smoke 
cigarettes.  
 
We also noted that Vietnam ranked the second largest exporter of coffee beans in the world, 
with coffee production accounted for 13% of total world coffee production in 2010 (Food and 
Agricultural Organisation 2016). However, the annual per capita consumption was 0.7 kg, 
compared with the average of 1.3 kg in the world , though the trend for Vietnamese 
consumption has increased dramatically over time (Jolliffe and Bui 2006). In comparison with 
the US standard cup of coffee, Vietnamese drinks coffee using a smaller cup, about 150ml. 
Nevertheless, it is conceived that Vietnamese coffee is more condensed in concentration than 
other cultures.  
 
Prior to exploring the biological mechanism of coffee in relation to T2DM, a brief review of 
coffee components is of value. Coffee beans contain many constituents, including lipids, 
proteins, carbohydrates, vitamins, and minerals. Consequently, isolating specific compounds 
responsible for the protective effects of coffee against T2DM is difficult. To date, the majority 
of research on the biological activity of coffee has mainly focused on caffeine. More recently, 
the acknowledgment that coffee and caffeine are not physiologically equivalent has led to the 
exploration of other coffee constituents (Farah et al. 2006, Johnston, Clifford, and Morgan 
2003, McCarty 2005, Nunes and Coimbra 2007, Shearer et al. 2003). It is evident that the 
contribution of coffee to the daily recommended intake of both macro- and micronutrients is 
minimal (Tunnicliffe and Shearer 2008). Despite this, its potential contribution cannot be 
entirely discounted. 
 
Previous studies had investigated a potential underlying mechanism regarding the beneficial 
effect of coffee consumption on insulin sensitivity (van Dam et al. 2004, Agardh et al. 2004). 




Coffee is a major source of chlorogenic acid and lignans, antioxidants that have beneficial 
effects on insulin sensitivity and glucose metabolism (van Dam 2006, Tunnicliffe and Shearer 
2008). Indeed, two studies have shown an association between coffee consumption and 
increased insulin sensitivity (Agardh et al. 2004, Ärnlöv, Vessby, and Risérus 2004). In another 
cross-sectional study, after adjustment for T2DM risk factors, coffee consumption was 
associated with significantly lower fasting plasma glucose concentrations (Bidel et al. 2006). 
These are in contrast with results from randomized controlled trials (van Dam, Pasman, and 
Verhoef 2004, Wedick et al. 2011, Ohnaka et al. 2012), where no indication of improvement 
of insulin sensitivity or secretion has been seen. The this discrepancy could be attributed to the 
short-term effects of coffee, which may even imply detrimental effects on insulin sensitivity 
(Keijzers et al. 2002) as different from long-term effects. There are, however, other possible 
pathways linking coffee to improved glucose tolerance. For example, Wedick et al. found 
indications of improved adipocyte and liver function following exposure to coffee (Wedick et 
al. 2011). The protective effect may also be attributed to the antioxidative properties of coffee. 
Indeed, data from an in vitro study suggested that caffeic acid, one of the major components of 
coffee, might protect against pancreatic islet destruction attributable to oxidative stress (Cheng 
et al. 2011). Therefore, mechanisms other than glucose metabolism and insulin resistance may 
play a role in how coffee drinking reduces diabetes risk.  
 
In addition, inflammatory markers and lipids may be involved apart from the insulin sensitivity 
related-mechanism. A recent intervention trial showed favourable effects of coffee on 
inflammatory markers and lipids but not on glucose metabolism (Kempf et al. 2010). Beneficial 
effects of coffee on T2DM risk could also be mediated by attenuation of subclinical 
inflammation, through decreased levels of interleukin-18 and up-regulation of adiponectin, as 
shown by Kempf et al. (Kempf et al. 2010). Caffeine did not appear to exert any protective 




effect against T2DM, but a reduced risk of T2DM has been linked to decaffeinated coffee 
intake (van Dam et al. 2006, Salazar-Martinez et al. 2004). With regard to coffee type, 
protective effects have been reported for both filtered and instant coffee (van Dam et al. 2006, 
Hjellvik, Tverdal, and Strom 2011). In Vietnam, filtered coffee is by far the most common 
type, contributing more than 79% of the total coffee consumption among our study participants, 
while decaffeinated coffee consumption is uncommon.  
 
5.3 Physical activity and T2DM risk 
 
Our study found that habitual physical activity was inversely associated with the T2DM risk. 
After adjusting for confounders, the inverse association appeared to be more prominent for 
participants whose moderate physical activity (either occupational or leisure-time activity) 
exceed 5 hours per week relative to those with 3 hours or less per week. Further analysis 
showed that total physical activity was inversely associated with the odds of T2DM, 
particularly for participants with more than 26 MET-hours per week compared to those with 
less than 13 MET-hours per week. Total physical activity was computed by summing activities 
with different intensities such as strenuous, vigorous and moderate activities. Of note, the 
majority of total physical activities were derived from moderate intensity activities. Both 
occupational and leisure time activity levels were measured using a validated and reliable 
instrument (Tran, Van Hoang, et al. 2013).  
 
Lifelong physical activity can offer a long-term assessment of physical activity on the 
development of T2DM. We categorised lifelong activity into 3 levels; “never been much 
involved in physical activity”, “intermittently active”, and “always been involved in physical 
activity”. In comparison to the “never been involved in physical activity”, apparent inverse 
associations with T2DM risk were found among individuals who were “intermittently active” 




and “always been involved in physical activity”. Our findings were consistent with previous 
studies which supported the beneficial role of lifelong activity to prevent T2DM (Warburton, 
Nicol, and Bredin 2006).  
 
In contrast, a sedentary lifestyle is a significant predictor for the development of T2DM. 
Previous research demonstrated that sedentary lifestyle may increase the risk of metabolic 
diseases including T2DM (Healy et al. 2008). Our study also found that sitting duration over 
35 hours per week versus less than 20 hours per week was associated with increased odds of 
T2DM after adjusting for confounders. 
 
The observed inverse association between regular moderate physical activity and T2DM risk 
has been reported in cohort studies of white populations such as USA, Finland, and UK 
(Weinstein et al. 2004, Hu et al. 2003, Hsia et al. 2005, Hu et al. 2001), but not in an Asian 
study (Okada et al. 2000). Hu et al. conducted a cohort study aimed to assess the association 
between physical activity and T2DM risk. Its findings demonstrated that doing physical activity 
was associated with a significant reduction in the risk of T2DM, whereas a sedentary lifestyle 
as indicated by television watching hours was directly associated with an elevated risk (Hu et 
al. 2001). Our findings similarly suggested a possible beneficial effect of moderate intensity 
activity and the increased odds of a sedentary lifestyle. However, this large prospective study 
was conducted on American men only whereas our case-control study examined on both men 
and women. Stratified analysis by sex in the present data indicated that the inverse association 
with T2DM risk observed in both men and women, but non-significant for the highest category 
of moderate physical activity. However, no interaction between sex and moderate activity 
(P=0.3) was found in our study. 




A recent meta-analysis also confirmed that about 31% reduction of T2DM risk could be 
achieved by regular participation in moderate intensity activity, as contrasted to being 
sedentary (Jeon et al. 2007). The meta-analysis included studies derived mostly from white 
populations while the present study was concerned with the Vietnamese population. We 
observed a similar result with a reduction of approximately 32% in T2DM risk. Furthermore, 
an inverse dose–response relationship was also evident in our study; a reduction of 3% and 2% 
in T2DM risk for each additional MET-hour per week of total physical activity for men and 
women, respectively.  
 
Physical activity can increase muscle glucose uptake and insulin sensitivity (Goodyear and 
Kahn 1998). During exercise, the increased need for metabolic fuel is met partially through an 
increase in the uptake and utilization of glucose. In the 1950s, studies of rats (Goldstein et al. 
1953) and perfused dog hind limbs (Huycke and KruhØFfer 1955) confirmed a phenomenon 
of decreased glucose concentration in the exercising muscle cells, and in the 1960s glucose 
uptake kinetics were first described using incubated frog sartorius muscles contracted in vitro 
(Holloszy and Narahara 1965, 1967). Since these early studies, a considerable amount of work 
has characterized the effects of exercise on glucose uptake in skeletal muscle, and a few reviews 
have concentrated on this topic (Richter E. A. 1996, Holloszy and Hansen 1996, Goodyear and 
Kahn 1998). In addition to the acute effects of physical activity to increase muscle glucose 
uptake, the period after physical activity is characterized by the muscle being more sensitive to 
the actions of insulin. This was first demonstrated in perfused rat hind limb muscles (Ivy and 
Holloszy 1981, Richter et al. 1982) and was subsequently shown in studies of human subjects 
(Xirouchaki et al. 2016, Richter et al. 1982, Iwabe et al. 2014). However, one-legged exercise 
models in humans have demonstrated that the exercise-induced increase in insulin sensitivity 
for glucose uptake is a local phenomenon restricted to the exercised muscles (Richter et al. 




1984, Richter et al. 1989). Furthermore, elevated capillary proliferation in muscles, increased 
muscle mass, and a higher proportion of more insulin sensitive types of muscle fibres, may all 
contribute to the beneficial effects of physical activity on insulin sensitivity (Goodyear and 
Kahn 1998).  
 
Obesity affects insulin resistance, which in turn leads to T2DM is a well-known mechanism. 
Obesity is known to increase peripheral insulin resistance (Després and Marette 1999, Boden), 
whereas physical activity seems to increase insulin sensitivity in skeletal muscles (Goodyear 
and Kahn 1998). Physical activity has consistently been a major predictor of weight control 
(Eriksson and Lindgarde 1991). Adipose tissue affects insulin metabolism by releasing free 
fatty acids and cytokines (Paolisso et al. 1995, Després and Marette 1999). Previous studies 
have provided evidence that large fat cells and high fasting plasma non-esterified fatty acids 
(NEFA) concentration are predictors of T2DM development (Paolisso et al. 1995). Studies 
showed that the predictive value of plasma NEFA on T2DM become non-insignificant after 
adjusting for acute insulin response, thus suggesting that NEFA may increase the T2DM risk 
by inhibiting insulin secretion. This hypothesis was supported by recent observations showing 
that NEFA may inhibit insulin release in vitro (Opara et al. 1994, Zhou and Grill 1994) through 
such actions has not demonstrated by several previous studies (Crespin, Greenough, and 
Steinberg 1969, Campillo et al. 1979). Opara et al. (Opara et al. 1994) revealed that a 20-min 
exposure of islet cells to 5 mmol/1 fatty acids resulted in enhancement or decrease of insulin 
secretions for C16:O or C18:2 fatty acids, respectively, whereas Zhou and Grill (Zhou and Grill 
1994) indicated that long-term exposure to increased NEFA concentration inhibited glucose-
induced insulin secretion. An alternative explanation is that the impaired insulin release results 
in increased lipolysis and thus causes elevated NEFA plasma levels. Lee et al (Lee et al. 1994) 
reported similar results making a strong case for the role of high plasma NEFA levels in the 




pathogenesis of T2DM in obese Zucker diabetic fatty rats, and defined the inhibitory effect of 
NEFA on beta-cell response to glucose. Besides, circulating NEFA levels can affect liver 
metabolism. It has been shown that NEFA inhibits insulin receptor binding and tyrosine kinase 
activity in isolated hepatocytes (Svedberg et al. 1992), and provides energy for 
gluconeogenesis thus increasing hepatic glucose output (Williamson, Browning, and Scholz 
1969, Foley 1992). However, since increased hepatic glucose production is not predictive of 
the development of T2DM (Lillioja et al. 1993), the impact of NEFA on liver metabolism is 
unlikely to play an important role in the aetiology of T2DM. Physical activity is one of the 
effective activities to sustain body weight control, which may, therefore, be a key mechanism 
to reduce the secretion of fatty acids and cytokines via decreasing adipose tissue volume, which 
in turn lessens the risk of T2DM. 
 
Another biological mechanism of physical activity was demonstrated to affect glucose 
metabolism. Such a mechanism has been identified independent of body fatness. Exercise can 
increase insulin-stimulated glycogen synthesis through a higher rate of insulin-stimulated 
glucose transport by GLUT4 glucose transporters and increased glycogen synthase activity 
(Perseghin et al. 1996). It has been demonstrated that an exercise-training program improved 
whole-body insulin sensitivity by 40% and whole-body nonoxidative glucose metabolism by 
60 to 70% in both the adult children of parents with T2DM and normal participants (Perseghin 
et al. 1996). Similar results in patients with T2DM and glucose tolerance have been shown in 
the literature (Oshida et al. 1989, Ryan 2000).   
 
5.4 Strength of the study 
Some strengths of the present study deserve mention regarding study design, sample size, data 
collection, and relevant research questions. This study used a hospital-based case-control 




design, which was inexpensive and appropriate for a lower-income country like Vietnam. The 
present study had relatively large number of cases of newly diagnosed T2DM patients. In 
addition, this design is suitable for the diseases with long latent period, such as cancers and 
T2D. Age and gender were used as matching criteria to reduce selection bias (Rothman, 
Greenland, and Lash 2008). The multivariate regression results have been adjusted for a 
comprehensive set of potential confounders, including socio-demographic factors, lifestyle, 
dietary, BMI, WHR, clinical and subclinical related factors. A relatively large sample size to 
assess different exposures, use of validated instruments for diet and lifestyle assessment, 
ascertainment of exposure variables via structured interviews, and uniform measurements of 
clinical and biochemical parameters across case and control groups. Special efforts will be 
made to increase response rates and minimise withdrawal of participants.  
 
5.5 Limitations 
Several limitations deserve mention in the present study, which include the use of hospital-
based controls, the introduced complexities of frequency matching, and the possible differential 
reporting of exposures. As a retrospective design in nature, the assessment of tea and coffee 
drinking habits may pose recall errors. Although we used a validated questionnaire to collect 
information on the habit of lifestyle and diet by face-to-face interview, inaccurate estimates of 
the amounts of tea and coffee consumption probably still occurred. Recall bias is a common 
issue in a case-control study however; this bias is minimized because we recruited non-diabetic 
patients in the same hospital as the T2DM patients so that they recall in the similar manner 
unlike healthy community-dwelling adults. Information bias was unlikely because all 
participants were blinded to the study hypothesis, while the potential protective effects of tea 
consumption; coffee consumption and physical activity against T2DM have not been 
established in Vietnam at the time of interview. Nevertheless, we were unable to determine the 




concentration of tea, as green tea including dried or fresh leaves is not commonly packaged 
with detailed content or portion size in Vietnam. Similarly, data on exposure estimates (tea, 
coffee consumption, and physical activity) for the underlying population are not available to 
compare with those from our control participants.  
 
Another source of bias could be introduced if individuals with T2DM changed their dietary 
habit linked to the onset of T2DM symptoms or diagnosis. To avoid reverse causation, incident 
patients were selected, i.e. newly diagnosed with T2DM within 4 weeks, while the referral 
period of habitual consumption of tea and coffee and other dietary factors was set at three years 
before the interview or diagnosis of T2DM. In addition, we excluded patients who had 
modified their lifestyle and diet due to any reason recently, as part of our selection criteria.  
 
Selection bias may arise if only severely ill patients are recruited and the controls are drawn 
from a different reference population. For this reason, we selected newly diagnosed (incident) 
T2DM patients, while non-diabetic controls are recruited from the outpatient clinics of the 
same hospital, who came from the same catchment areas as the cases but were unlikely to share 
the same risk profiles.  
 
Despite the low non-responsive rate, selection bias may be unavoidable because all participants 
were voluntary to participate in the study. In addition, the hospital-based controls were selected 
from the same hospital as cases instead of randomly selected from the community and the 
participating hospital serves the entire catchment region. Residual confounding such as healthy 
lifestyles might still exist despite established and plausible risk factors have been controlled 
for in the multivariable logistic regression analyses. Further replications of the study are 
necessary before generalizing the findings to the general and other populations. 




CHAPTER 6. CONCLUSION 
 
 
This is the first case-control study in Vietnam investigating the association between diet (green 
tea and coffee consumption) and lifestyle (physical activity) and T2DM risk. In addition, the 
epidemiology of T2DM has been reviewed systematically and its findings suggest an 
increasing trend in the prevalence of T2DM in Vietnam. Although factors related to the 
increasing occurrence of T2DM in previous observational studies were also suggested, 
evidence was inadequate for the formulation of an effective control and prevention strategy of 
T2DM in Vietnam. Therefore, we reported the first case-control study’s findings to ascertain 
the association with T2DM risk for tea and coffee consumption, and physical activity. All the 
objectives stated in Chapter 1 have been achieved successfully.   
 
6.1 The epidemiology of T2DM 
T2DM is one of the chronic diseases, which has increased dramatically worldwide.  Recent 
evidence indicated that T2DM is now problematic in both developed and developing countries. 
To systematically review the prevalence rates of T2DM and its risk factors in Vietnam, 
electronic databases namely PubMed, Web of Science, Wiley Online Library, and Scopus, 
were searched to identify the relevant literature. The search resulted in 10 studies, including 2 
national surveys and 8 regional investigations. National prevalence estimates of T2DM were 
2.7% in 2002 and 5.4% in 2012. The estimates for the northern region were 1.4% in 1994 and 
3.7% in 2012 and those for the southern region were 3.8% in 2004, 7.0% in 2008, and 12.4% 
in 2010. The risk factors of T2DM included older age, urban residence, high levels of body and 
abdominal fat, physical inactivity, sedentary lifestyle, genetic factors, and hypertension. The 
prevalence rate by gender was variable in both national and regional studies. There was 




insufficient information available on some potentially important risk factors such as smoking, 
dietary intake, income, and educational level. In conclusion, our review indicated a rapidly 
growing prevalence of T2DM in Vietnam over the past decade and suggested that extra effort 
will be required for prevention and control. 
 
Dietary and lifestyle factors pertinent to Vietnamese offer an opportunity for protection against 
this emerging chronic disease. Therefore, a relatively inexpensive hospital-based case-control 
study was conducted to investigate the association between these abovementioned factors (tea 
consumption, coffee consumption, and physical activity) and T2DM risk among Vietnamese 
adults. 
 
6.2 Green tea consumption and T2DM risk 
Green tea is the second most common beverage in Vietnam after water. In the literature, green 
tea consumption has been suggested to be protective against T2DM.  A hospital-based case-
control study was conducted between 2013 and 2015, involving a total of 1198 participants 
(599 T2DM cases, 599 controls). Results showed an inverse association between green tea 
consumption and T2DM risk; a reduced T2DM odds of 41% for those who drank >4 cups per 
day relative to the reference group of non-drinkers after adjusting for plausible confounders. 
The dose-response relationship was also significant, with reduced odds of T2DM by increasing 
the quantity (cups) of green tea consumed per day. In addition, the cumulative exposure to 
green tea consumption was found to reduce significantly the risk of T2DM among adults. Green 
tea drinking is not only part of the Vietnamese dietary culture but also other Asian cultures, 
which have been shown to be a protective factor against T2DM in the literature, consistent with 
our case-control study. In conclusion, green tea consumption should be extended to non-tea 
drinkers in our community to take up the tea drinking habit.  




6.3 Coffee consumption and T2DM risk 
Coffee is one of the most common beverages drank in Western populations. Although coffee 
consumption has been shown to be associated with a lower risk of T2DM in Western countries, 
little is known about coffee drinking pattern and its relationship with T2DM risk among Asian 
populations. This hospital-based case-control study provides the first such report in Vietnam. 
Overall, our results support for the beneficial role of habitual coffee consumption in reducing 
the risk of T2DM after adjustment for plausible confounding factors. We further found that the 
inverse association with T2DM risk among women was more apparent than men, consistent 
with previous studies. For those women who drank 1-3 cups per day, a significant reduction of 
T2DM risk was observed, whereas such inverse association was weaker for men. Indeed, the 
interaction term between sex and T2DM was statistically significant. Participants who were 
male smokers accounted for more than 61%, while only 1% of women reported as current or 
former smokers. It appears that smoking may confound the relationship between coffee 
drinking and T2DM risk. In conclusion, coffee consumption was associated with a reduced risk 
of T2DM in Vietnamese women. 
 
6.4 Physical activity and T2DM risk 
Physical activity can affect the development of T2DM, where intensity and frequency of 
physical activity are important aspects. In the present study, the relationship between physical 
activity and the risk of T2DM among Vietnamese adults was investigated. After adjustment for 
plausible confounding factors, significant reductions in T2DM risk were observed among 
participants undertaking moderate intensity activities (both occupational and leisure-time 
activity) relative to those who did light physical activity. Total physical activity level was 
computed as the summation of activities with different intensity levels such as strenuous, 
vigorous, and moderate activities, but mostly was derived from moderate intensity activities. 




Our findings showed that total physical activity level was inversely associated with T2DM, 
with a 31% odds reduction observed among individuals engaging 26 MET-hours per week 
relative to those with less than 13 MET-hours per week. Data also indicated a significant, 
inverse trend of association between total physical activity and T2DM; each MET-hour 
increment per week was associated with a 3% and 2% lower risk of T2DM in men and women, 
respectively. The data reported here supported the concept that T2DM may be prevented by 
increasing overall physical activities, particularly moderate activity in leisure time and 
occupational settings.  
 
6.5 Recommendations 
Our case-control study results showed that habitual consumptions of green tea and coffee were 
inversely associated with the T2DM risk among Vietnamese adults. Besides, maintaining 
regular moderate intensity activities may provide an apparent benefit to reduce the T2DM risk. 
The findings are crucial and potentially contribute to the development of evidence-based 
guidelines for individuals at risk of T2DM to improve their diet and lifestyle, with the ultimate 
goal to control and prevent this emerging epidemic in Vietnam. The hospital-based case-control 
design is relatively inexpensive and thus appropriate to facilitate future replications in similar 
low- and middle-income countries in Asia.  
 
As little information on tea and coffee drinking is available in Vietnam, our study contributes 
to better understanding the preventive effects of these beverages. However, due to limitations 
and biases inherent in our retrospective study design (as discussed in the previous chapter), 
cause-and-effect relationship could not be established. Therefore, it is important to conduct 
large-scale prospective cohort studies and randomised controlled trials to determine the 
protective effects of tea and coffee consumption for the development of incident T2DM. This 




thesis focused on tea and coffee consumption and physical activity, other modifiable lifestyle 
(alcohol drinking and cigarette smoking) and plausible dietary factors of T2DM (traditional 
foods such as fish, fruits, and vegetables as reviewed in Chapter 2) should be investigated in 
the future. Similarly, it may be worthwhile to examine the rural/urban differences in T2DM 
incidence and to perform stratified analyses by residential location. 
 
Similarly, physical activity has been suggested as a protective factor for T2DM and other non-
communicable diseases. Consistent with the literature, the present study found the similar 
benefit of moderate physical activity in reducing the risk of T2DM. A recent WHO STEP 
survey in Vietnam reported that seven-in-ten Vietnamese people aged 25–64 years 
meet the WHO recommendations for total physical activity. However, total physical activity 
was mainly derived from work-related activities (Van Bui et al. 2015). Therefore, changes in 
infrastructure and surroundings in the community are essential to improve the level of 
exercise among Vietnamese adults. Finally, randomised controlled trials, using objective 
measurements such as pedometers and/or accelerometers to assess types and intensities of 
physical activities, should be implemented to evaluate the effectiveness of physical activity to 
control and manage impaired glucose status. Regular exercise should be promoted 
and recommended as part of a healthy lifestyle and body weight control for the prevention of 
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Appendix A: Information sheet and consent form 
 
Information letter  
School of Public Health 
        Curtin University 
        GPO Box U 1987 
     Perth, WA 6845, Australia 
 
Project Title: A Case-control Study of Risk Factors for Type 2 Diabetes Mellitus in Vietnam 
My name is Nguyen Thanh Chung. I am a medical and public health researcher, and have a 
medical degree from Vietnam and a Master of Public Health degree from Curtin University, 
Australia. I am investigating the dietary factors relating to the development of type 2 diabetes 
in Vietnamese adults. In this project, I will interview people with and without type 2 diabetes. 
I am interested to find out what you eat and drink as well as your lifestyle habits such as 
smoking and alcohol consumption. I will also ask you several questions regarding your health 
status and demographic details. Each face-to-face interview will take about 40 minutes to 
complete.  
Your participation in this research is completely voluntary. You can refuse any specific 
question that you are uncertain or find it difficult to answer. During the interview, if you decide 
to withdraw from the study, please feel free to do so because there will be no negative 
consequences; especially with respect to the treatment you are receiving at this hospital. I can 
assure you that your treatment or therapy will not be affected at all by participation in this 
study. 
After you have signed the enclosed consent form, I will assume that you have agreed to 
participate, and you allow me to use your data in this research project. The information you 
provided will be kept strictly confidential, and your identity will remain anonymous. Only 





Please be assured that your information will only be accessed by the chief investigator of this 
project, and not anyone else. In particular, it will not be released to the medical staff and 
authority of this hospital. Your completed questionnaire and other documents will be kept in a 
locked cabinet for five years at Curtin University before being destroyed.  
If you require further information about this study, please do not hesitate to contact me. 
 
This study has been approved by the Curtin University Human Research Ethics Committee 
(Approval Number HR105/2013). The Committee is comprised of members of the public, 
academics, lawyers, doctors and pastoral carers.   If needed, verification of approval can be 
obtained either by writing to the Curtin University Human Research Ethics Committee, Office 
of Research and Development, Curtin University, GPO Box U1987, Perth, 6845 or by 
telephoning 9266 2784 or by emailing hrec@curtin.edu.au. 
 
Thank you very much for your participation in this research project. Your contribution is 










Professor Andy Lee  
Phone: +61-8-92664180  
Email:Andy.Lee@curtin.edu.au 




   
 
Consent form 
I, ________________________, have read the information on the attached letter, and have 
been informed about the purpose of this research project. 
I agree to participate in this research, but have the option to change my mind and withdraw at 
any time.  





I understand that all information provided by me will be treated as confidential and that my 
identity will remain anonymous. 
I understand that no individual data will be used except in aggregated form for subsequent 
reporting purpose. 
 
This study has been approved by the Curtin University Human Research Ethics Committee 
(Approval Number HR105/2013). The Committee is comprised of members of the public, 
academics, lawyers, doctors and pastoral carers.   If needed, verification of approval can be 
obtained either by writing to the Curtin University Human Research Ethics Committee, Office 
of Research and Development, Curtin University, GPO Box U1987, Perth, 6845 or by 
telephoning 9266 2784 or by emailing hrec@curtin.edu.au. 
 
 








Name of witness 
 



















Professor Andy Lee  
Phone: +61-8-92664180  
Email:Andy.Lee@curtin.edu.au 
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  TELEPH0NE 92662784 
FACSIMILE 92663793 






• You have ethics clearance to undertake the research as stated in your proposal. 
• TheapprovalnumberforyourprojectisHR 
105/2013.Pleasequotethisnumberinanyfuturecorrespondence. 















Ourwebsitehttps://research.curtin.edu.au/guides/ethics/non low risk hrec 
forms.cfmcontainsallotherrelevantformsincluding: 
• CompletionReport(tobecompletedwhenaprojecthasceased) 




























Case-Control Study of Risk Factors for Type 2 Diabetes Mellitus in Vietnam 
The interviewee is: [   ] Case [   ] Control 
Questionnaire ID: CA/____/____ 
Case/“hospital number”/ “case number” 
CO/____/____/____ 
Control/“hospital number”/“control number” 
Diagnosis:   
Medical record ID:   
Department :   
Hospital:  
Date of interview: _____/_____/_____  (dd/mm/yyyy) 
Date of completion: _____/_____/_____  (dd/mm/yyyy) 
Interviewer ID:  
Structure of the questionnaire: 
A. Demographic information 
B. Anthropometric measurements (direct measurement) 
C. Clinical information (extract from medical record) 
D. Personal and family medical history 
E. Lifestyle 





A. Demographic information 
A1.  Name of interviewee:  
A2.  
Address 
Number:                                    ; Street:                                       commune/ward: 
District:                                                              ; Province: 
A3.  Contact number (home phone/mobile)  [….............................../...............................] 
A4.  Contact phone for next-of-kin [.................................../...............................] 
A5.  Date of Birth 
 
______/_____/ _____ (dd/mm/yyyy) 
 
……....................years 
A6.  Gender 0 [   ] Male  1 [   ] Female 
A7.  Marital status 
0 [   ] Never married  
1 [   ] Married/de facto 
2 [   ] Widowers/divorced/separated 
A8.  Age at marriage                                   ...................years 
A9.  Occupation (before retirement) 
0 [   ] Farmer 
1 [   ] Manual worker 
2 [   ] Office clerk 
3 [   ] Teacher 
       4 [   ] House worker  
       5 [   ] Other:………………………………..                 
A10.  Retirement status 0 [   ] Not retired 1 [   ] Retired 
A11.  What is the highest level of education you have completed? 
0 [   ] No formal education 
1 [   ] Primary school 
2 [   ] Secondary school 
3 [   ] High school 
4 [   ] College/vocational school/University 
B. Anthropometric measurements 
B1.  Blood pressure (I will measure 2 times your arterial blood pressure and your pulse rate at your left arm) 


















B4.  Height ___ ___ ___.___ Centimetres 
B5.  What is your weight three years ago? ___ ___ ___.___ Kilograms 





B7.  Waist circumference ___ ___ ___.___  Centimetres 
B8.  Hip circumference ___ ___ ___.___  Centimetres 
 
C. Clinical information 
C1.  Diagnosis at hospital: 
 
1 [   ] Fasting plasma glucose 
2 [   ] 2h OGTT 
3 [   ] other, ________________________ 
 
C2.  Date of diagnosis .........../ …........./ …......... (dd/mm/yyyy) 
C3.  Fasting plasma glucose …………………mmol/l 
C4.  2h OGTT …………………mmol/l 
C5.  HbA1C …………………% 
C6.  Triglycerides …………………mmol/l 
C7.  LDL cholesterol …………………mmol/l 
C8.  HDL cholesterol …………………mmol/l 
C9.  Total cholesterol …………………mmol/l 
D. Personal and family medical history 
D1.  Have you been diagnosed of (self-report)? 
Year of diagnoses 
Yes [    ]     No [    ]  …………………….Hypertension      
Yes [    ]     No [    ]  …………………….Coronary heart disease     
Yes [    ]     No [    ] ……………………. Myocardial infraction 
Yes [    ]     No [    ] ……………………. Heart failure 
Yes [    ]     No [    ]  …………………….Cardiomyopathy 
Yes [    ]     No [    ]  …………………….Cardiac dysrhythmia  
Yes [    ]     No [    ]  …………………….Hypertensive heart 
disease  
Yes [    ]     No [    ]  …………………….Inflammatory heart 
disease 
Yes [    ]     No [    ]  …………………….Valvular heart disease  
Yes [    ]     No [    ]  …………………….Cerebrovascular 
disease 
Yes [    ]     No [    ]  …………………….Peripheral arterial 
disease 
Yes [    ]     No [    ]  …………………….Congenital heart 
disease 
Yes [    ]     No [    ]  …………………….Hypercholesterol 
Yes [    ]     No [    ]  …………………….Hyperlipidemia  
Yes [    ]     No [    ]  …………………….Gout  
Yes [    ]     No [    ]  …………………….Foot ulcers 
Yes [    ]     No [    ]  …………………….Pneumonia  
Other, 
……………………………………………………………….. 
D2.  In your family, is there anyone who has suffered from diabetes? 
0 [   ] No 





D3.  If yes, is the person your? 1 [   ] father         2 [   ] mother  3 [   ] brother       4 [   ] sister 
D4.  
List of cormobidity (hospital 
medical records) 
 
1. ……………………………………year [………….] 
2. ……………………………………year [………….] 
3. ……………………………………year [………….] 
4. ……………………………………year [………….] 
5. ……………………………………year [………….] 
6. ……………………………………year [………….] 
7. ……………………………………year [………….] 
8. ……………………………………year [………….] 
9. ……………………………………year [………….] 
10. ……………………………………year [………….] 
11. ……………………………………year [………….] 
12. ……………………………………year [………….] 
13. ……………………………………year [………….] 
14. ……………………………………year [………….] 
15. ……………………………………year [………….] 
 
E. Lifestyle 
No. Physical activity 
Before the disease, how long, on the average, in a day (/week) did you spend in the following sitting activities? 
E1.  Sitting in car or bus 
.….hrs…....mins/day  Or :….….hrs….....mins/week 
E2.  Riding on motorbike 
.….hrs…....mins/day  Or :….….hrs….....mins/week 
E3.  Sitting at work (e.g. sewing, at office or factory…) 
…….….hrs….....mins/day Or.….hrs….....mins/week 
E4.  
Other sitting activities (e.g. watching TV, eating meals, 
reading, playing cards, listening radios, computer 
games…) …….….hrs….....mins/day Or.….hrs….....mins/week 
E5.  Sleeping time (including afternoon naps) 
…….….hrs….....mins/day Or.….hrs….....mins/week 
E6.  
Lifelong physical activity involvement was defined as ‘(doing) active sports or vigorous exercise or work long 
enough to get sweaty, at least twice a week’ 
How would you describe your physical fitness activity 
over your entire life course? 
0 [   ] Never been much involved 
1 [   ] Previously active but not any more  
2 [   ] Active just recently 
3 [   ] Intermittently active 
4 [   ] Always been involved 
Before the disease, how long, on the average, in a day (/week) did you spend in the following physical activities? 
E7.  Strenuous sports (i.e. jogging, bicycling on hills, tennis, badminton, swimming, aerobics) 
 
.….hrs….....mins/day Or .….hrs….....mins/week 
E8.  
Vigorous work (i.e. moving heavy furniture, shovelling, 
weight lifting, loading/ unloading trucks, or equivalent 
manual labour) 






Moderate activity (i.e. housework, brisk walking, 
golfing, bowling, bicycling on level ground, gardening, 
Taichi) 
.….hrs…....mins/day  Or :….….hrs….....mins/week 
Exposure to cigarette smoking [adopted from(WHO 2008b)] 
E10.  Are you a 
0 [   ] never smoker?  
1 [   ] former smoker? 
2 [   ] current smoker? 
If 0, => F13 
E11.  
On average, how many of the 
following tobacco products do you 
smoke per day? 
Manufactured cigarettes? 
Hand-roll cigarettes? 
Pipes full of tobacco? 
Cigars, cheroots or cigarillos? 
Number of water pipe sections? 
Any others? Specify……………………... 
.…......….  per day 
.…......….  per day 
.…......….  per day 
.…......….  per day 
.…......….  per day 
.…......….  per day 
E12.  How many years have (had) you been smoking? 
…….….…………. years or since age…….. 
E13.  Are your relatives/people living with you smoking at home? 
0 [   ] No 
1 [   ] Yes 
 
 
F. Food frequency questionnaire [adopted from (Kusama et al. 2005)] 
General dietary habit – please recall your habit three years ago 
No Questions Answer 
F1.  Are you on a special diet listed below now or 3 years ago?          
 
0 [   ] No 
1 [   ] Vegetarian 
2 [   ] Low fat 
3 [   ] Low salt 
4 [   ] Other: ……………………… 
 
F2.  Do you have meals regularly (having 3 meals per day) 
1 [   ] Regularly 
2 [   ] Occasionally irregular 
3 [   ] Sometime irregular 
4 [   ] Often irregular 
 
F3.  





Eating take-away food or eating out: 
Eating snacks (Biscuits, melon seeds): 
Eating sweet food (candy, congee…): 
 
1 [   ]everyday     2 [   ]frequently     3 [   ]occasionally   4 [   ] never 
1 [   ]everyday     2 [   ]frequently     3 [   ]occasionally   4 [   ] never 
1 [   ]everyday     2 [   ]frequently     3 [   ]occasionally   4 [   ] never 
1 [   ]everyday     2 [   ]frequently     3 [   ]occasionally   4 [   ] never 
 
F4.  Did you or any of your family members feel your food was salty? 
0 [   ] never 
1 [   ] sometimes 





F5.  When you eat meat, did you trim off all the fat? 
0 [   ] never 
1 [   ] sometimes 
2 [   ] usual 
F6.  When you ate chicken, did you eat the skin 
0 [   ] never 
1 [   ] sometimes 
2 [   ] usual 
F7.  
How often do you eat the following types of food? (How many times per Year/Month/Week/Day?) 
Fried food: ......... times/[   ]Y     [  ]M     [  ]W     [  ]D 
Smoked food: ......... times/[   ]Y     [  ]M     [  ]W     [  ]D 
Cured food: ......... times/[   ]Y     [  ]M     [  ]W     [  ]D 
Grilled food: ......... times/[   ]Y     [  ]M     [  ]W     [  ]D 
F8.  How often do you use vegetable cooking oil? ......... times/[   ]Y     [  ]M     [  ]W     [  ]D 
F9.  How often do you use pork lard? ......... times/[   ]Y     [  ]M     [  ]W     [  ]D 
F10.  
When you eat, how often do you use the following seasonings?  
Fish sauce: 
......... times/[   ]Y     [  ]M     [  ]W     [  ]D 
Salt: 
......... times/[   ]Y     [  ]M     [  ]W     [  ]D 
Soybean sauce: 
......... times/[   ]Y     [  ]M     [  ]W     [  ]D 
Tomato sauce: 
......... times/[   ]Y     [  ]M     [  ]W     [  ]D 
F11.  Within the last 3 years, have you changed you diet habit 0 [   ] No 
1 [   ] Yes 
F12.  
If yes, please specify: 
- How you have changed: …………………………………………………………………………………… 
 




Consumption of beverage: How often/what amount of/ how did you drink the following beverage? – Please 
tell us about your dietary habits 3 years ago. 
 









F13.  Beer ____times/[  ]Y    [  ]M    [  ]W    [  ]D 300ml  cup (A)   
F14.  Home-made rice wine 
____times/[  ]Y    [  ]M    [  ]W    [  ]D 
30ml cup (B) 
  
F15.  Home-made herbal rice wine ____times/[  ]Y    [  ]M    [  ]W    [  ]D 30ml cup (B)   
F16.  
Strong bottled liquor 
(≥ 39% alcohol; e.g. 
vodka) ____times/[  ]Y    [  ]M    [  ]W    [  ]D 







Light bottled liquor (≤  
29% alcohol; e.g. 
small bottle vodka) ____times/[  ]Y    [  ]M    [  ]W    [  ]D 
30ml cup (B) 
  
F18.  Red wine ____times/[  ]Y    [  ]M    [  ]W    [  ]D 100ml cup (C)   
F19.  White wine ____times/[  ]Y    [  ]M    [  ]W    [  ]D 100ml cup (C)   
F20.  Within the last 3 years, have you changed your drinking habit for any type of liquor above? 
0 [   ] No 
1 [   ] Yes 
If yes, please tell us the reasons for that change? 
 
F21.  Green tea (dried) ____times/[  ]Y    [  ]M    [  ]W    [  ]D 100ml cup (D)   
F22.  Green tea leave ____times/[  ]Y    [  ]M    [  ]W    [  ]D 200ml cup (E)   
F23.  Black tea ____times/[  ]Y    [  ]M    [  ]W    [  ]D 100ml cup (D)   
F24.  Oolong tea ____times/[  ]Y    [  ]M    [  ]W    [  ]D 100ml cup (D)   
F25.  Within the last five years, have you changed your drinking habit for any type of tea above? 
0 [   ] No 
1 [   ] Yes 
 
If yes, please tell us the reasons for that change? 
 
F26.  Black coffee ____times/[  ]Y    [  ]M    [  ]W    [  ]D 150ml cup (F)   
F27.  Instant coffee 
____times/[  ]Y    [  ]M    [  ]W    [  ]D 
Bag 
5gr spoon (H) 
……..bag 
…….spoon  
F28.  Milk coffee ____times/[  ]Y    [  ]M    [  ]W    [  ]D 150ml cup (G)   
F29.  Within the last 3 years, have you changed your drinking habit for any type of coffee above? 
0 [   ] No 
1 [   ] Yes 
 If yes, please tell us the reasons for that change? 
 
F30.  Water  _____times/day 250ml cup __________cup 
F31.  Soy milk ____times/[  ]Y    [  ]M    [  ]W    [  ]D 250ml cup __________cup 
F32.  Lemon juice ____times/[  ]Y    [  ]M    [  ]W    [  ]D 250ml cup __________cup 
F33.  Orange juice ____times/[  ]Y    [  ]M    [  ]W    [  ]D 250ml cup __________cup 
F34.  Coconut water ____times/[  ]Y    [  ]M    [  ]W    [  ]D 250ml cup __________cup 
F35.  Fruit shake juice ____times/[  ]Y    [  ]M    [  ]W    [  ]D 250ml cup __________cup 
F36.  What type of fruits did you drink the most? 
1 [   ] mango 
2 [   ] guava 
3 [   ] water melon 
4 [   ] avocado 
5 [   ] custard apple       
6 [   ] paw paw 
7 [   ] Pineapple 
8 [   ] sapodilla 
9 [   ] Other:.......................... 





F38.  What type of soft drinks did you drink the most? 
1 [   ] Coca cola  
2 [   ] Pepsi 
3 [   ] Fanta                  
4 [   ] Nestea 
5 [   ] Icetea 
6 [   ] Other canned soft drink 
F39.  
 
Did you add sugar into your drinks, such as tea, coffee or orange 
juice? If yes, how many spoons (5g) did you add? 
 
 
0 [   ]  No 
1 [   ]  Yes, ……….spoons  
 
Consumption of soy bean products, vegetables and fruits  
How often do you eat soy bean products? 
 
No Food item Frequency (per month/week/day) Unit (PS) 
Quantity/meal? 
(½ PS, 1PS, 1.5PS...) 
F40.  Fried tofu ____times/[  ]Y    [  ]M    [  ]W    [  ]D Piece (I) ______PS 
F41.  Raw tofu ____times/[  ]Y    [  ]M    [  ]W    [  ]D Piece (I) ______PS 
F42.  Soybean curd with sweet syrup ____times/[  ]Y    [  ]M    [  ]W    [  ]D Small bowl (J) ______PS 
 
Consumption of vegetables- How often/what amount of/ how did you eat vegetables? 
 
F43.  Tomato ____times/[  ]Y    [  ]M    [  ]W    [  ]D Whole ______PS 
F44.  Bean sprout ____times/[  ]Y    [  ]M    [  ]W    [  ]D Small bowl (L) ______PS 
F45.  Amaranth, Jute potherb ____times/[  ]Y    [  ]M    [  ]W    [  ]D Small bowl (L) ______PS 
F46.  Water spinach ____times/[  ]Y    [  ]M    [  ]W    [  ]D Small bowl (L) ______PS 
F47.  Mustard green, Chinese cabbage ____times/[  ]Y    [  ]M    [  ]W    [  ]D Small bowl (L) ______PS 
F48.  Malabar nightshade ____times/[  ]Y    [  ]M    [  ]W    [  ]D Small bowl (L) ______PS 
F49.  Crown-daisy ____times/[  ]Y    [  ]M    [  ]W    [  ]D Small bowl (L) ______PS 
F50.  Chinese leek ____times/[  ]Y    [  ]M    [  ]W    [  ]D Small bowl (L) ______PS 
F51.  Cabbage ____times/[  ]Y    [  ]M    [  ]W    [  ]D Small bowl (L) ______PS 
F52.  French bean ____times/[  ]Y    [  ]M    [  ]W    [  ]D Small bowl (L) ______PS 
F53.  Pumpkin ____times/[  ]Y    [  ]M    [  ]W    [  ]D Small bowl (L) ______PS 
F54.  Gourd ____times/[  ]Y    [  ]M    [  ]W    [  ]D Small bowl (L) ______PS 
F55.  Cucumber ____times/[  ]Y    [  ]M    [  ]W    [  ]D Small bowl (L) ______PS 
F56.  Broccoli ____times/[  ]Y    [  ]M    [  ]W    [  ]D Small bowl (L) ______PS 
F57.  Chinese yam (green) ____times/[  ]Y    [  ]M    [  ]W    [  ]D Small bowl (L) ______PS 





F59.  Ash gourd, wax gourd ____times/[  ]Y    [  ]M    [  ]W    [  ]D Small bowl (L) ______PS 
F60.  Bitter melon ____times/[  ]Y    [  ]M    [  ]W    [  ]D Small bowl (M) ______PS 
F61.  Capsicum ____times/[  ]Y    [  ]M    [  ]W    [  ]D Small bowl (N)  
F62.  Carrot ____times/[  ]Y    [  ]M    [  ]W    [  ]D Whole (O) ______PS 
F63.  White potato ____times/[  ]Y    [  ]M    [  ]W    [  ]D Whole (O) ______PS 
F64.  Sweet potato ____times/[  ]Y    [  ]M    [  ]W    [  ]D Whole (P) ______PS 
 
Consumption of fruits - How often/what amount of/ how did you eat fruit? 
 
F65.  Dragon fruit ____times/[  ]Y    [  ]M    [  ]W    [  ]D Whole ______PS 
F66.  Banana ____times/[  ]Y    [  ]M    [  ]W    [  ]D Whole ______PS 
F67.  Papaya ____times/[  ]Y    [  ]M    [  ]W    [  ]D Piece 20x4cm (Q)  ______PS 
F68.  Pomelo ____times/[  ]Y    [  ]M    [  ]W    [  ]D Piece (R)  ______PS 
F69.  Longan ____times/[  ]Y    [  ]M    [  ]W    [  ]D Kg ______kg 
F70.  Orange ____times/[  ]Y    [  ]M    [  ]W    [  ]D Whole ______PS 
F71.  Water melon ____times/[  ]Y    [  ]M    [  ]W    [  ]D       Piece 100 gr (S) ______PS 
F72.  Pear ____times/[  ]Y    [  ]M    [  ]W    [  ]D Whole ______PS 
F73.  Grape ____times/[  ]Y    [  ]M    [  ]W    [  ]D Kg ______kg 
F74.  Guava ____times/[  ]Y    [  ]M    [  ]W    [  ]D Whole ______PS 
F75.  Apple ____times/[  ]Y    [  ]M    [  ]W    [  ]D Whole ______PS 
F76.  Lychee ____times/[  ]Y    [  ]M    [  ]W    [  ]D Kg ______kg 
F77.  Mangoes ____times/[  ]Y    [  ]M    [  ]W    [  ]D Whole ______PS 
F78.  Durian ____times/[  ]Y    [  ]M    [  ]W    [  ]D Piece (T) ______PS 
 
 
Consumption of sweet varieties - How often/what amount of/ how did you eat sweet varieties? 
 
No 
Food item Frequency (per month/week/day) Unit 
Quantity/meal? 
(½ PS, 1PS, 1.5PS...) 
F79.  
Sweet soup (made of 
glutinous rice and 
bean, corn…) ____times/[  ]Y    [  ]M    [  ]W    [  ]D 






F80.  Please choose 3 types that you eat the most? 
1 [   ] Glutinous soup with taro 
2 [   ] Glutinous soup with corn 
3 [   ] Glutinous soup with mung bean 
4 [   ] Glutinous soup with black bean 
5 [   ] Glutinous soup with white bean 
6 [   ] Mix glutinous soup with bean 
7 [   ] Other:........................ 
F81.  Sweet cakes  ____times/[  ]Y    [  ]M    [  ]W    [  ]D Piece (V) ______PS 
F82.  Biscuits ____times/[  ]Y    [  ]M    [  ]W    [  ]D Piece ______PS 
 
Consumption of bread and rice varieties - How often/what amount of/how did you eat the following items? 
 
F83.  
French type bread 
(either plain or with 
meat) 
____times/[  ]Y    [  ]M    [  ]W    [  ]D Load (W) ______PS 
F84.  Sliced bread (either plain or with meat) ____times/[  ]Y    [  ]M    [  ]W    [  ]D Slice ______PS 
F85.  Rice-based noodles ____times/[  ]Y    [  ]M    [  ]W    [  ]D Large bowl (X) ______PS 
F86.  Wheat-based noodles ____times/[  ]Y    [  ]M    [  ]W    [  ]D Large bowl (X) ______PS 
F87.  Instant noodle ____times/[  ]Y    [  ]M    [  ]W    [  ]D Bag ______PS 
F88.  Plain rice (at home) ____times/[  ]Y    [  ]M    [  ]W    [  ]D Small bowl ______PS 
F89.  
Rice comes in a 
serving (a plate of 
fried rice, broken 
rice…) when eating 
outside 
____times/[  ]Y    [  ]M    [  ]W    [  ]D Plate ______PS 
F90.  
Glutinous rice (either 
plain, with bean, or 
salted) 
____times/[  ]Y    [  ]M    [  ]W    [  ]D Small bowl ______PS 
F91.  Rice porridge ____times/[  ]Y    [  ]M    [  ]W    [  ]D Large bowl (KK) ______PS 
 
 
Consumption of meat- How often/what amount of/how did you eat? 
 
No Food item Frequency (per month/week/day) Unit (PS) 
Quantity/meal? 
(½ PS, 1PS, 1.5PS...) 
F92.  Pork lean ____times/[  ]Y    [  ]M    [  ]W    [  ]D Small piece(Y) ______PS 
F93.  Pork medium fat ____times/[  ]Y    [  ]M    [  ]W    [  ]D Small piece(Z) ______PS 
F94.  Pork rib ____times/[  ]Y    [  ]M    [  ]W    [  ]D Small piece(AA) ______PS 
F95.  Pork lower leg ____times/[  ]Y    [  ]M    [  ]W    [  ]D Small piece(BB) ______PS 
F96.  Pork steak ____times/[  ]Y    [  ]M    [  ]W    [  ]D Piece 60g (CC) ______PS 





F98.  Chicken ____times/[  ]Y    [  ]M    [  ]W    [  ]D Small piece(EE) ______PS 
F99.  Pigeon ____times/[  ]Y    [  ]M    [  ]W    [  ]D Small piece(FF) ______PS 
F100.  Duck ____times/[  ]Y    [  ]M    [  ]W    [  ]D Small piece(FF) ______PS 
F101.   Pork heart ____times/[  ]Y    [  ]M    [  ]W    [  ]D gram ______gr 
F102.   Pork liver ____times/[  ]Y    [  ]M    [  ]W    [  ]D gram ______gr 
F103.   Pork kidney ____times/[  ]Y    [  ]M    [  ]W    [  ]D gram ______gr 
F104.   Chicken heart ____times/[  ]Y    [  ]M    [  ]W    [  ]D gram ______gr 
F105.   Chicken liver ____times/[  ]Y    [  ]M    [  ]W    [  ]D gram ______gr 
F106.   Chicken kidney ____times/[  ]Y    [  ]M    [  ]W    [  ]D gram ______gr 
 
Consumption of fish, egg and milk- How often/what amount of/how did you eat? 
 
F107.  Sea fish (Mackerel, tuna...) ____times/[  ]Y    [  ]M    [  ]W    [  ]D Piece 70g (GG) ______PS 
F108.  Please check two types of sea fish that you eat the most often? 
1 [   ] Mackerel 
2 [   ] Tuna 
3 [   ] Mullet 
4 [   ] other, specify…………………….. 
F109.  Fresh water fish (Tilapia...) ____times/[  ]Y    [  ]M    [  ]W    [  ]D Piece 50g (HH) ______PS 
F110.  Please check two types of fresh water fish that you eat the most often? 
1 [   ] Tilapia 
2 [   ] Snake-head 
3 [   ] Carp 
4 [   ] Chep 
5 [   ] Other, specify…………………….. 
F111.  Shrimp ____times/[  ]Y    [  ]M    [  ]W    [  ]D Whole (II)  ______PS 
F112.  Squid/octopus ____times/[  ]Y    [  ]M    [  ]W    [  ]D Piece (JJ) ______PS 
F113.  Sea shells ____times/[  ]Y    [  ]M    [  ]W    [  ]D Small bowl ______PS 
Egg 
F114.  Chicken egg ____times/[  ]Y    [  ]M    [  ]W    [  ]D Whole  ______PS 
F115.  Duck egg ____times/[  ]Y    [  ]M    [  ]W    [  ]D Whole ______PS 
Preserved food 
F116.  Pickle vegetable & garlic ____times/[  ]Y    [  ]M    [  ]W    [  ]D gram gr 
F117.  Fermented soy product ____times/[  ]Y    [  ]M    [  ]W    [  ]D gram gr 





F119.  Preserved meat (sausage…) ____times/[  ]Y    [  ]M    [  ]W    [  ]D gram gr 
Milk 
F120.  Cow whole milk ____times/[  ]Y    [  ]M    [  ]W    [  ]D Cup 250ml  ______PS 
F121.  Soya milk ____times/[  ]Y    [  ]M    [  ]W    [  ]D Cup 250ml  ______PS 
F122.  Milk powder, whole ____times/[  ]Y    [  ]M    [  ]W    [  ]D 5gr spoon (H) ______PS 
F123.  Yogurt ____times/[  ]Y    [  ]M    [  ]W    [  ]D Box ______PS 
F124.  Condensed milk ____times/[  ]Y    [  ]M    [  ]W    [  ]D ml (C) ______PS 
 
 
Dietary supplements - How often/what amount of/how did you use? 
 
No. Item Frequency Unit Quantity /time (unit) 
Years of 
use 
F125.  Multivitamin  ____times/[  ]Y    [  ]M    [  ]W    [  ]D Tablet   
F126.  Vitamin A  ____times/[  ]Y    [  ]M    [  ]W    [  ]D Tablet   
F127.  Vitamin C  ____times/[  ]Y    [  ]M    [  ]W    [  ]D Tablet   
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